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Living Sweet: A Multi-Functional Mobile-Phone Application Strategy for Adults with
Uncontrolled Type 2 Diabetes Mellitus
Chantel Anderson DNP, APRN, FNP-BC
Type 2 Diabetes Mellitus (T2DM), one of the most common chronic diseases, is increasing
worldwide, and once diagnosed, lifetime self-management is critical to maintain glycemic control
(Vermeire et al., 2005; American Diabetes Association (ADA), 2018). Management of T2DM has
been acknowledged as challenging due to the need for strict lifestyle adaptations. From a public
health perspective, uncontrolled diabetes leads to increased healthcare costs, secondary
complications, and ultimately severe disabilities (ADA, 2018). The purpose of this evidencebased practice (EBP) project was to evaluate the effectiveness of a diabetes-specific mobile
health application (MHA) on glycated-hemoglobin (HbA1C), self-care perception (SCP), and
self-care behaviors (SCB). The Iowa model was used to guide this project in primary care
settings in Northwest Indiana. A retrospective chart review determined that a high number
adults had uncontrolled T2DM. A protocol was developed and implemented over an 8-week
period. A within group design was used for pre and post-intervention evaluation of the HbA1C
and SCP using paired-samples t tests. Statistically significant differences were noted in preHbA1C (M = 9.95; SD = 1.07) compared to post-HbA1C (M = 8.21; SD = 1.10) (t = 6.674, df =
17, *p < 0.05), and in pre-SCP (M = 34.6; SD = 10.5) compared to post-SCP (M = 42.6; SD =
8.09) (t = -4.403, df = 17, *p < 0.05). A statistically significant difference in project-specific preand post- intervention SCBs were found with the behaviors of checking glucose (Z = 2.389, *p <
.05), recording glucose (Z = 2.666, *p < .05), and medication adherence (Z = 2.313, *p < .05).
There was not a statistically significant difference in the perception of activity engagement (Z =
1.718, p > .05). Results indicated that a MHA intervention had a statistically and clinically
significant impact on HbA1C, SCP, and SCBs with the exception of activity engagement.
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CHAPTER 1
INTRODUCTION
Despite being the most expensive healthcare system among developed countries, the
U.S. ranks the lowest in key health outcomes and in many aspects of access to care (Bondurant
& Armstrong, 2016). Additionally, changes in reimbursement structure and challenges related to
both quality and healthcare cost beg for a healthcare reform. Health care payment methods are
changing from fee-for-service to value-based systems where payment is based on clinical
quality outcomes and cost containment (Greenwood, Gee, Fatkin, & Peeples, 2017). From a
public health perspective, uncontrolled diabetes leads to increased healthcare costs, secondary
complications, and ultimately severe disabilities (ADA, 2018).
Chronic disease management has been acknowledged as challenging due to the need
for strict lifestyle adaptations (Vermeire et al., 2005). Type 2 Diabetes Mellitus (T2DM), one of
the most common chronic diseases, is increasing worldwide, and once diagnosed, lifetime selfmanagement is critical to maintain glycemic control. Glycemic control is defined as achieving a
HbA1C level that ranges from 6.0 % to 7.0 %, or blood glucose averages of 126 mg/dl to 152
mg/dl respectively, which has direct correlation with long-term prognosis for patients with T2DM
(ADA, 2018). Glycemic control for diabetics who have experienced blood sugars less than 60
are expected to achieve less stringent HbA1C levels of < 8.0% (ADA, 2018). HbA1C
measurement signifies the average blood sugar over a 8 to 12-week timeframe. Research has
indicated that adherence to traditional interventions for the treatment of diabetes mellitus is
poor, and as a result there has been little improvement of glycemic control (Vermeire et al.,
2005).
The aim of managing T2DM is to attain glycemic control (ADA, 2018). Self-care
behaviors and lifestyle modifications are aimed at overall reduction of HbA1C levels and are
mainstays in the treatment and management of Diabetes Mellitus (DM) (ADA, 2018). Thus, the
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diffusion into practice of the best evidence for the self-management of diabetes is essential as
the management of chronic disease becomes a focus throughout health organizations.
Uncontrolled diabetes and chronic hyperglycemia are also associated with increased risk for
cardiovascular disease, retinopathy, nephropathy, neuropathy (ADA, 2018; Vermeire et al.,
2005), as well as increased mortality for those who suffer with this unforgiving disease (Wu et
al., 2017).
Through an extensive literature search, evidence indicated that the use of mobile health
applications (MHAs) was found to be the best practice for the encouragement of self-care
practices for the management of adults with T2DM and found to a significantly reduce HbA1C
levels (Alharbi et al., 2016; Bonoto et al., 2017; Clement et al., 2018; Cui, Wu, Mao, Wang, &
Nie, 2016; Hou, Carter, Hewitt, Francisa, & Mayor, 2016; Pal et al., 2014; Wang, Xue, Huang,
Huang, & Zhang, 2017; Whitehead & Seaton, 2016; Wu, Guo, & Zhang, 2019; Wu et al., 2017;
Yoshida et al., 2018). In 2014 64 % of Americans were using smartphone technology. Research
indicates that using a diabetes MHA through a smartphone can increase adherence to diabetes
management and self-care efforts (Fu et al., 2017). MHA technology provides a platform for the
rapid development of patient-centered care that supports the self-management of DM beyond
traditional computer or web-based programs, and institution-based diabetes education
programs (Greenwood, Gee, Fatkin, & Peeples, 2017).
The purpose of this evidence-based practice (EBP) project is to evaluate the
effectiveness of a diabetes-specific mobile health application (MHA) on HbA1C levels, self-care
perception, and self-care behaviors. The clinical question being addressed is, what is the best
practice for adult T2DM patients to achieve glycemic control and improve self-care behaviors.
Additionally, the clinical question also addresses the impact of a MHA on self-care perception.
This project was posed to identify what intervention has been found in the best evidence, to
achieve glycemic control in adult T2DM patients, thereby lessening debilitating complications
related to chronically elevated HbA1C levels.
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Data from the Literature Supporting Need for the Project
Currently, 30.3 million people have DM in the U.S., this number includes an alarming
estimation of 7.2 million who have gone undiagnosed (ADA, 2018; CDC, 2017). T2DM affects
382 million globally, and the incidence of this disease is expected to increase to 500 million by
2030 (ADA, 2018; CDC, 2017; Fu, McMahon, Gross, Adam, & Wyman, 2017; Hou, Carter,
Hewitt, Francisa, & Mayor, 2016). The percentage of adults with diabetes increases with age;
25.5% of those aged 65 and older have been diagnosed with this chronic disease (CDC, 2017).
Of an estimated 1.5 million new cases diagnosed in 2015, more than half were aged 45-65
years and equally distributed among men and women (CDC, 2017). Coexisting conditions and
complications secondary to uncontrolled diabetes include cardiovascular disease, stroke,
diabetic ketoacidosis, kidney disease. eye disease, and amputation of a lower extremity (CDC,
2017). In the U.S., major cardiovascular diseases were found in 1.5 million diabetics which
included 400,000 with ischemic heart disease, and 251,000 stroke events. Amputations of the
lower extremities as a result of uncontrolled diabetes occurred 11.5 per 1,000 persons with
diabetes (CDC, 2017). In 2015, other uncontrolled diabetes-related events led to 14.2 million
emergency department visits from hypoglycemia (very low blood sugar) and hyperglycemia
(very high blood sugar) (CDC, 2017). This chronic disease was the seventh leading cause of
death in the U.S. in 2015, and had an estimated cost of $245 billion (CDC, 2017). Economic
costs of untreated and uncontrolled DM increased 26% from 2012 to 2017 (ADA, 2018; Fu et
al., 2017). Poor self-management practice lead to uncontrolled HbA1C levels (greater than 8.0),
and have led to significant financial burden to the individual and to society (ADA, 2018). The
ongoing responsibility of administering medication, testing blood glucose levels, and adhering to
lifestyle modifications can be quite overwhelming, furthermore, patients often do not typically
document self-management behaviors. From a clinical experience perspective, the lack of
documentation creates a significant challenge for health care providers to identify the problem
and adjust therapy to meet the needs of the individual.
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Data from the Clinical Agency Supporting Need for the Project
This project is a pilot program that will be implemented in primary health care settings
within the guidelines of certified rural health centers. These clinical sites are located in rural
Indiana, are family practice focused, and have a medical group consisting of physicians and
nurse practitioners. The four facilities are located in small rural towns in northwest Indiana. The
clientele is generally one of lower socio-economic status with the main payor source received
from Medicare and Medicaid Services. After an electronic medical record (EMR) query, it was
found that well over 200 patients on service had either type I diabetes mellitus (T1DM) or T2DM
(Melissa Jones, Personal Communication, May 23, 2019). Organizational data, obtained
through personal communication with the project preceptor, indicated poor outcome measures
in 2019 quarter-one and quarter-two for HbA1C measurements of patients with diabetes
mellitus. Centers for Medicare and Medicaid Services (CMS) specifically evaluate HbA1C levels
of greater than 9.0 as the quality outcome measure for health care organizations (CMS, 2017).
However, for the purpose of this project the ADA recommendation of HbA1C of 8.0 will be the
used for evaluation purposes (ADA, 2018). Quarter-one indicated that 59.3% of diabetics within
the primary care organization had HbA1C results of greater than 9.0, while quarter-two indicated
that 66% had HbA1C greater than 9.0. These are considered poor quality measure outcomes
and are well above the expected national standard of 45% (CMS, 2017). These poor-quality
outcome results were the impetus for this EBP project. As a primary healthcare organization, it
is the duty of those rendering care to seek out the best evidence and improve quality and safety
of the receiving population. Within the practice in which the DNP student works, HbA1C levels
above 9.0 % were at an all-time high of 59% for the second quarter in 2019. The 59% was less
than the overall primary care group’s results of 66% of DM patients that had HbA1C of greater
than 9.0%, but levels were still outside of the national standard (CMS, 2017).
The DNP student manages 40 adults with T2DM, and has over 10 years’ experience
treating and managing patients with this chronic disease. She has found it difficult to incite self-
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care behavior practices that positively impact HgA1C levels. Through an extensive search of the
literature, evidence was found to support an intervention to improve the self-management of
adults with T2DM.
Purpose of the Evidence-Based Practice Project
The purpose of this EBP project is to evaluate the effectiveness of using a diabetesspecific MHA, with associated individualized preference settings, as an 8-week intervention for
adult T2DM patients with HbA1C levels above 8.0 in a primary healthcare setting. There is a
large body of evidence that supports the use of diabetes-specific mobile health smartphone
applications to significantly reduce HbA1C in this population. Essentially, this EBP project will
include an intervention designed to foster behavioral changes that promote improved HbA1C
results, diabetes self-management habits such as; medication compliance, blood sugar
monitoring efforts, and physical activity engagement, and improve self-care perception.
Evaluation will include determining if it significantly improved HbA1C results, self-care behaviors
of blood glucose monitoring, physical activity engagement, medication adherence, and self-care
perceptions for adult T2DM patients in a primary healthcare setting.
Living Sweet
The name of the new diabetes-specific MHA program was created through a competition
held by the DNP student project leader. The competition was conducted through an email
request not only to name the program, but also to entice staff engagement and interest. This
approach was aligned with a transformational leadership model to motivate, inspire, and solicit
buy-in of staff members who may be impacted by practice change (Brewer et al., 2016). The
winning name of the competition, Living Sweet, was chosen by the mother of the DNP student
project leader. Staff are key stakeholders and it is important for their participation in the adoption
of new practice standards and for overall program success (Walston, 2017).
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PICOT Question
In adult T2DM patients with HbA1C values higher than 8.0 in a primary healthcare
setting (P) what is the effect of a diabetes-specific multi-functional mobile-phone application (I)
compared to traditional diabetes education (C) on HbA1C results, self-care behaviors, and selfcare perception (O), over an 8-week period (T)?
Significance of the EBP Project
According to Vermeire et al. (2005) irrespective of the type of chronic disease,
adherence to treatment recommendations are poor despite known consequences. This EBP
project is important because it is a proactive approach that encourages adult T2DM patients to
increase self-care behaviors which are directly associated with a reduction in HbA1C values
(Alharbi et al., 2016; Bonoto et al., 2017; Clement et al., 2018; Cui, Wu, Mao, Wang, & Nie,
2016; Fu, McMahon, Gross, Adam, & Wyman, 2017; Hou, Carter, Hewitt, Francisa, & Mayor,
2016; Pal et al., 2014; Wang, Xue, Huang, Huang, & Zhang, 2017; Whitehead & Seaton, 2016;
Wu, Guo, & Zhang, 2019; Wu et al., 2017; Yoshida et al., 2018). Moreover, studies have shown
use of MHAs have a positive impact on self-care perception and self-confidence that is essential
for self-management of a chronic disease (Bonoto et al., 2017; Clement et al., 2018; Pal et al.,
2014; Wu, Guo, & Zhang, 2019). Improvements in HbA1C is directly linked to a reduction of
debilitating diabetes complications, cost burden, and associated mortality rates (Alharbi et al.,
2016; Bonoto et al., 2017; Yoshida et al., 2018). The use of MHAs addresses the current clinical
problem through a technological platform that has shown statistically significant improvements
in HbA1C results and accompanying self-care behaviors (Alharbi et al., 2016; Bonoto et al.,
2017; Clement et al., 2018; Cui, Wu, Mao, Wang, & Nie, 2016; Fu, McMahon, Gross, Adam, &
Wyman, 2017; Hou, Carter, Hewitt, Francisa, & Mayor, 2016; Pal et al., 2014; Wang, Xue,
Huang, Huang, & Zhang, 2017; Whitehead & Seaton, 2016; Wu, Guo, & Zhang, 2019; Wu et
al., 2017; Yoshida et al., 2018). Additionally, use of this technology has been shown to be costeffective, readily available, and user friendly (Alharbi et al., 2016; Clement et al., 2018; Holtz &
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Lauckner, 2012; Pamaiahgari, 2018). The ADA’s Standards of Medical Care in Diabetes (2019)
recommendations indicate that improving care and promoting health in the diabetic population is
a standard of practice included in their evidence-based recommendations. Additionally, the ADA
concluded that diabetes-specific technology, when applied appropriately, can improve the lives
and health of people with diabetes (ADA, 2019).
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CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Overview of EBP Model
Evidence-based practice (EBP) involves the use of reliable, explicit and judicious
evidence to make decisions about the care of individual patients combining the results of welldesigned research, clinical expertise, patient concerns and patient preferences (Titler et al.,
2001). The best evidence is used as a guide to practice decisions which ultimately leads to high
quality standards, controlled costs, and optimal patient care outcomes (Schmidt & Brown,
2019). Ingersoll (2000), defines EBP as, “the conscientious, explicit, and judicious use of theoryderived, research-based information in making decisions about care delivery to individuals or
groups of patients and in consideration of individual needs and preferences” (p. 152).
The Iowa model was originally developed and implemented at the University of Iowa
Hospitals and Clinics. It was used as a framework that focused on organization and
collaboration incorporating clinical practice and use of research (Titler et al., 2001). Since its
inception this model has been used to guide project decisions while focusing on evidence to
support best practice effort (Titler et al., 2001). Originally, it was developed in 1994 as a
research utilization model, but has been updated to include more emphasis on EBP. Significant
developments in the healthcare market and feedback from users was the impetus to revise the
model. Revisions included: incorporating new terminology and feedback loops; address the
dynamic changes within the health care market; and encourage the use of other forms of
evidence such as expert opinion and case reports when primary research was not available to
guide practice. The model was ultimately renamed to the Iowa Model of Evidence-Based
Practice to Promote Quality Care (Titler et al., 2001). This updated model allows nurses to focus
on knowledge and problem-focused triggers that promoted critical thought about clinical practice
effectiveness and operational efficiency, leading nurses to seek scientific knowledge to fill the
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clinical and operational gaps within a unit or throughout an organization (Titler et al., 2001). The
Iowa Model of Evidence-Based Practice to Promote Quality Care consists of 7 steps to promote
quality care in a systematic method that demonstrates how organizations change practice
based on the most current evidence (Schmidt & Brown, 2019). Step I is the selection of a topic
for an EBP project for which many factors need to be considered including assessment of the
priority and magnitude of the problem, the application to the primary healthcare setting, the
contribution to improving care, the current practice problem area, staff dedication to practice
change, and multidisciplinary impact of the problem (Titler et al., 2001). Step II is the
engagement of a team that will be responsible for the development, implementation, and
evaluation of the project. The makeup of the team is driven by the chosen topic and include
associated stakeholders (Titler, 2001). In this step the team will determine whether the problem
at hand is a priority for the organization, department, or unit in which they work. Problems that
have a higher volume or cost associated will likely have a higher priority from an organizational
standpoint. During this step, organizational buy-in is crucial and knowing the prioritization of the
problem will help focus team efforts when grooming key stakeholders (Titler et al., 2001).
Step III entails evidence retrieval. Brainstorming amongst the members should be held
to identify available resources to guide the search for evidence (Titler et al., 2001). Once the
priority has been determined, the team members will help develop, evaluate, and implement the
EBP change. The team should include interested interdisciplinary stakeholders and leaders,
which include those outside of nursing (Titler et al., 2001). Step IV is the process of gathering,
critiquing and synthesizing pertinent research related to the desired practice change. This is a
systematic process that exposes the best supportive evidence available which is then assessed
and critiqued for level and quality (Titler et al., 2001). This ensures the overall body of evidence
has strength and merit (Schmidt & Brown, 2019). One of the most important parts of this step is
to formulate a good question using the PICOT method (Titler et al., 2001) that takes into
account the population, intervention, comparison, outcome, and time frame (Melnyk & Fineout-
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Overholt, 2015). Step V is the development of a patient-centered evidence-based practice
standard that is highly individualized. Once the literature is critiqued, team members develop a
set of recommendations that guide the new practice (Titler et al., 2001). The type and strength
of evidence used in practice needs to be clear and based on the consistency of replicated
studies (Titler et al., 2001). The development of a patient-centered EBP standard becomes a to
guide clinical practice, assessments, actions, and treatment as required, and will be based on
the group decision, considering the relevance for practice, its feasibility, appropriateness,
meaningfulness, and effectiveness for practice (Titler et al., 2001). Evidence-based practice is
ideally a patient-centered approach and when implemented is highly individualized (Titler et al.,
2001). Practice that fails to consider individual preferences of the individual patient is not
evidence-based. Evidence-based practice must take into account patient autonomy, choice, and
allow personal preference to be expressed (Schmidt & Brown, 2019; Titler, 2001).
Step VI is the implementation of the EBP standard which begins with written policies,
procedures, and guidelines. Policy development requires direct interaction between the team
members, direct care providers, and organizational leaders to support the practice change
(Titler et al., 2001). The evidence also needs to be disseminated with the focus on its strengths
and perceived benefits. This can be achieved through various communication lines such as inservice education and hands on demonstration of the new practice change. Social and
organizational factors can affect implementation and there needs to be support and value
placed on the integration of evidence into practice and the application of research findings
(Schmidt & Brown, 2019). The expertise of nurse champions can support the overall
implementation of EBP into an organization. Nurse champions represent an untapped vital
resource to change practice in today's metric-driven culture (Scanlon & Woolforde, 2016).
Empowerment and a multidisciplinary approach are a few of the key attributes that have
propelled the success of the nurse champion. Moreover, they have the ability to close the gap
between evidence and practice as well as increase staff engagement in the work setting
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(Scanlon & Woolforde, 2016). In some cases organizations are not ready or willing to assimilate
EBP. Elements of system readiness include tension for change, EBP system fit, assessment of
implications, support and advocacy for the EBP, dedication of time and resources, and the
capacity to evaluate the impact of the EBP during and following implementation. Moreover,
leadership support is critical for supporting EBP, and is expressed by providing necessary
resources, materials, and time (Titler, 2006).
Step VII is the evaluation step which is essential to seeing the value and contribution of
the evidence into practice. Baseline comparison data prior to project implementation is
beneficial to show how the new evidence-based practice standard has contributed to patient
care (Titler, 2001). Audits and feedback should be conducted throughout the implementation
process. It is essential that organizational leadership provide support during this step as
success is not likely without support. Project evaluation will certainly bring to light the EBP
project’s impact, but the project’s value to the organization can only be assessed against an
actual change occurring with the desired outcome. For any change to take place, barriers that
could hinder its progress need to be identified and addressed preferably before and
during project implementation (Schmidt & Brown, 2019).
Application of EBP Model to DNP Project
The application of Step I of the Iowa model, which is the selection of a topic, consisted of
the project leader identifying a problem-focused trigger which raised the question: Is this topic a
priority for the organization? Consultation with the organization’s quality and compliance director
and project preceptor led the team to investigate quality metrics that surrounded HbA1C
measures throughout the primary care organization. An internal data search revealed the
priority and magnitude of the current problem directly related to elevated HbA1C measures and
uncontrolled T2DM. Current practice problems were assessed and care rendered was found to
be outdated and lacking EBP standards. First-quarter quality measures of 2019 indicated that
59% of diabetic patients within this primary healthcare organization in rural Indiana submitted
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reports of HbA1C results of greater than 9%. Second-quarter quality measures reports for this
same organization resulted in 66% of diabetic patients with HbA1C levels greater than 9%.
These value translate into an average daily blood sugar of 215 mg/dl., and were the impetus for
this EBP project. According to the ADA (2018) the goal HbA1C ranges from 6.0% - 7.0% or an
average daily blood sugar of 115 mg/dl to 150mg/dl. However, there are multiple factors the
dictate target HbA1C for those individuals with diabetes mellitus; for those with more severe
disease, control of diabetes is to achieve a HbA1C of 8% is recommended (ADA, 2018).
Step II, forming a team, consisted of the project leader selecting key team players for the
development, implementation, and evaluation of the project. The team composition was
determined based on the project topic and includes key stakeholders such as primary care
providers, senior leadership, and a compliance and quality director. Initiation of this step
includes a PowerPoint presentation that will educate key stakeholders about the new practice
change. The presentation is designed to provide project details and engender enthusiasm for
the EBP project. This effort is to encourage buy-in from key stakeholders, as well as enhance
recruitment of additional team members and champions within the organization.
Step III, evidence retrieval, entails an exhaustive literature search and active
brainstorming with team members to identify resources available to support the evidence search
process. The exhaustive literature search involves gathering the most current and relevant
evidence to support the best practice for the treatment of HbA1C that is greater than 8% and is
considered to be uncontrolled.
Step IV, grading the evidence, consisted of the project leader leveling and appraising
evidence consistent with predetermined inclusion criteria. The focus is to get high-level and
high-quality evidence to determine what the best practice should include and to support the
reason for the change in practice. Literature that is high in level and quality adds substantial
validity, strength, and merit to the new EBP standard, and this leads to improved patient quality
and safety outcomes.
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Step V, developing an EBP standard, will be completed by the team members of the
project which includes the project leader, DNP Student, two primary care providers that will
serve as project champions, a project preceptor who is the quality and compliance director, and
a risk management director.
Step VI, implement the EBP, includes the execution of the written guidelines specific to
the triggered problem. This phase necessitates the translation and application of evidence into
practice. This process will include a multidisciplinary approach between team members, direct
care providers, and organizational leaders.
Step VII, evaluation, will be ongoing during and after the implementation of the new EBP
practice change. Internal individual baseline HbA1C data has been gathered prior to the launch
of this 8-week pilot in order to evaluate the outcome of the new evidence-based practice
change. This is essential to allow stakeholders and team members to see the value and
contribution of applying evidence into practice.
Strengths and Limitations of EBP Model for DNP Project
Strengths of the model include the use of a pilot program launch to address barriers,
redesign implementation processes, and fine tune the written and practice standards toward a
final EBP protocol. Within the model are continuous feed-back, check and balance loops that
evaluated different points as one proceeds through the steps. The inclusion of these key
decision points are specific to this model, and help guide the project leader and the project team
members to make determinations about the overall progression of the project. This process
supports a project that is focused and valid, and one that is most likely to succeed and be in
alignment with organizational priorities. An example within the model is a question that is posed:
Is there sufficient research regarding the use of mobile phone applications for self-management
of T2DM? If there is not sufficient research to support this theme then one may choose to
conduct a study or choose a different problem. This check and balance system is infused
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throughout the model to ensure the team efforts are not futile and will lead to a productive new
practice change that is evidence-based.
The limitation of this model is the focus of a team approach to bring the new practice
change to fruition. In a rural healthcare setting, resources, including nursing staff are not
abundant by any means. Due to lack of resources and inadequate staffing many are reluctant to
join a team of any kind, especially over a long period of time. Many feel overwhelmed with work
and the addition of team involvement is perceived as additional work and commitment. Based
on personal experience as a leader in other service excellence programs, it is best to keep the
team small in a rural health setting. Dissemination of the new practice change may be a
different story, but the planning, developing, and implementing will need to be kept to an
intimate group of team members. The practice change will be instituted in the primary care
office settings and not the organization as a whole. As reimbursement transitions from volume
to value in which quality trumps quantity, HbA1C reduction and diabetic control is going to be
critical to maintain a viable practice within a healthcare setting (Bondurant & Armstrong, 2016).
Literature Search
An exhaustive literature search was conducted within the electronic databases Cochrane
Library, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Joanna Briggs
Institute, Medline with full text via EBSCO, U.S. Preventative Services Task Force (USPSTF)
PsycINFO, and Turning Research Into Practice (TRIP). Citation chasing of a single-arm
feasibility study by Koot et al. (2019) was completed and resulted in a relevant SR and metaanalysis by Bonoto et al. (2017). A hand search was completed in the Journal of Medical
Internet Research (2016) and one article was found to be significant in the creation of this EBP
project.
Keywords from the PICOT question were used in each respective database. Initial
searches included several variances of those keywords to lead to a suitable relevant evidence
search. The following keywords, phrases, Boolean Operators, and truncation options in various
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combinations were used to retrieve the best evidence within each respective database; “mobile*
phone” OR “mobile* app*” OR “cell* phone” OR “mobile application*” OR “smart phone” AND
diabetes* OR diabetic* OR “diabetes mellitus”.
Inclusion criteria were adult patients with T2DM who utilized mobile phone applications
to foster ADA-approved diabetic self-care activities such as medication compliance, blood sugar
monitoring efforts, and physical activity engagement to reduce HbA1C levels. Self-care
perception was noted as a theme throughout the literature, therefore, studies that addressed
self-care perception related to the use of MHAs for diabetic self-care were included. Limiters
were peer-reviewed, research articles or Cochrane Reviews in English language conducted
between January 2014 and June 2019. Exclusion criteria were children and adults with
gestational diabetes, prediabetes, T1DM, and other telehealth technologies that were not MHA
focused. Some of the evidence included data on theses exclusion grouping (Alharbi et al., 2016;
Bonoto et al., 2017; Clement et al., 2018; Hou, Carter, Hewitt, Francisa, & Mayor, 2016; Mann,
2018; Pamaiahgari, 2018; Whitehead & Seaton, 2016; Wu et al., 2017; Wu, Guo, & Zhang,
2019; Yoshida et al., 2018), but subgroup analysis data were extracted when available from the
literature to focus on the evidence related to inclusion criteria (Bonoto et al., 2017; Clement et
al., 2018; Hou, Carter, Hewitt, Francisa & Mayor, 2016; Pal et al., 2014; Wang, Xue, Huang,
Huang, & Zhang 2017; Whitehead & Seaton, 2016; Wu et al., 2017; Wu, Guo, & Zhang, 2019;
Yoshida et al., 2018). Search of the CINAHL database produced 47 sources that had varying
degrees of level, relevance and quality. References were read in two-phase process, first by
reviewing titles and abstracts, and then by reviewing the full article, and five sources were
selected. These sources were one meta-analysis of RCTs (Yoshida et al., 2018), one
systematic review of RCTs (Whitehead & Seaton, 2016) , two SRs and combined meta-analysis
of RCTs (Pal et al., 2014; Hou, Carter, Hewitt, Francisa, & Mayor, 2016), and one integrative
review of RCTs with four group pre-post-test studies (Fu, McMahon, Gross, Adam, & Wyman,
2017). The Cochrane Library yielded 73 sources and none were applicable to the focus of this
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project. Additional pieces of evidence were excluded due to redundancy and lack of relevance
to the focus of this project. Joanna Briggs Institute database resulted in 17 sources and three
evidence summaries were selected for relevance (Mann, 2018; Nguyen, 2018; Pamaiahgari,
2018). Medline with full text EBSCO yielded 242 sources, and after applying a two-phase
evaluation process a total of four evidence sources were found (Wu et al., 2017; Wu, Guo, &
Zhang, 2019; Cui, Wu, Mao, Wang, & Nie, 2016; Wang, Xue, Huang, Huang, & Zhang, 2017).
The two-phase evaluation process consisted of reviewing abstracts followed by a more in-depth
analysis of each respective article. The pieces of evidence included one SR (Wu et al., 2017),
two SRs with combined meta-analysis (Wu, Guo, & Zhang, 2019; Cui, Wu, Mao, Wang, & Nie,
2016), and one integrative review (Wang, Xue, Huang, Huang, & Zhang, 2017). This database
search results included five articles duplicated from previous database. It was noted that other
researchers within the literature searched the database PsycINFO within the articles, so this
database was added to the search. The search of PsycINFO yielded 14 sources, in which none
were relevant to this EBP project. Turning Research Into Practice (TRIP) clinical practice
guideline database was utilized and yielded 10 sources, one clinical practice guideline was
found to be relevant and qualified for inclusion into the pool of evidence (Clement et al., 2018).
Finally, the U.S. Preventative Services Task Force (USPSTF) was included in the search, which
resulted in two sources; however, neither was found to be relevant to this EBP project. In
addition to searching the databases, citation chasing through a related article (Koot et al., 2019)
outside of database-retrieved evidence, yielded 2 significant pieces of evidence (Bonoto et al.,
2017; Cui, Wu, Mao, Wang, & Nie, 2016). Hand searching efforts were completed in the Journal
of Medical Internet Research, Volume 18, 2016 to 2017, on related articles and yielded one
significant piece of evidence (Alharbi et al., 2016). This particular year was selected in the hand
search process due to the amount of new literature that was in support of MHAs for the support
of chronic disease such as diabetes.
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An exhaustive search of the literature resulted in 15 pieces of evidence involving the
effect of MHAs to reduce HbA1C in patients with T2DM and perceptions of self-care in the
management of T2DM. Using the leveling system by Melnyk & Fineout-Overholt (2015), 12 of
the sources included were deemed level 1 evidence, and were either systematic reviews,
evidence summaries, or systematic reviews combined with meta-analysis. Two pieces were
deemed level II evidence and consisted of integrated reviews. One piece of evidence was a
clinical practice guideline which was deemed level VII. The included 15 sources was comprised
of three evidence summaries (Mann, 2018; Nguyen, 2018; Pamaiahgari, 2018), one metaanalysis (Yoshida et al., 2018), eight systematic reviews (Wu et al., 2017; Whitehead & Seaton,
2016; Hou, Carter, Hewitt, Francisa, & Mayor, 2016; Cui, Wu, Mao, Wang, & Nie, 2016; Alharbi
et al., 2016; Wu, Guo, & Zhang, 2019; Pal et al., 2014; Bonoto et al., 2017), two integrative
reviews (Fu, McMahan, Gross, Adam, & Wyman, 2017; Wang, Xue, Huang, Huang, & Zhang,
2017), and 1 clinical practice guideline (Clement et al., 2018) (see Table 2.1).
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Table 2.1
Literature Search Results
Database

CINAHL

Keyword(s)

Limiters

(Subject
Heading:
Diabetes
Mellitus, Type
2. “mobile*
phone” OR
“mobile app*”
OR “mobile
application*”
OR “cell
*phone” OR
“smart phone”).

English Peer
Reviewed
Research
article

May 2014June 2019

English Peer
Reviewed

May 2014June 2019

2

2 (Systematic
Reviews and
Meta-Analysis
of RCTs).

Cochrane
Reviews

May 2014June 2019

73

0(Redundancy
of evidence or
not relevant to
topic).

English Peer
Reviewed

Volume 182016

1

1 (Systematic
Review and
Meta-Analysis
of RCTs).

(diabetes
mellitus, type 2
diabetes,
mobile phone,
application,
app,
smartphone,
cell phone).

English Peer
Reviewed

May 2014June 2019

17

3 (Evidence
Summaries).

(“mobile*phone”
OR “mobile*
app” OR “cell”
phone” OR

English Peer
Reviewed
Research
article

May 2014June 2019

242

3 (Systematic
Review and
MetaAnalysis,

Citation
Chase Koot
et al., 2019

Cochrane
Library

Hand Search
Journal of
Medical
Internet
Research
Joanna
Briggs
Institute

Medline with
Full text via
EBSCO

(Diabetes
Mellitus, type 2,
Explode all
trees).

Date
Restraints

Results

47

Relevant
Evidence
5 (1 MetaAnalysis of
RCTs, 1
Systematic
Review, 2
Systematic
Reviews and
MetaAnalysis, 1
Systematic
Review of
RCTs and 4
group prepost-test).
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“mobile
application*”
OR “smart
phone” AND
diabetes* OR
diabetic* OR
“diabetes
mellitus”).
PsycINFO

(Thesaurus:
Diabetes
“mobile*” phone
OR “mobile
app*” OR “cell*
phone” OR
“smart phone”).

TRIP Turning (smart phone
Research
diabetes).
Into Practice
USPSTF
U.S.
Preventative
Services
Task Force

(Diabetes
Metabolic).

1 Systematic
Review of
RCTs,
1 Systematic
Review of
RCTs and
Quasiexperiments).
English Peer
Reviewed

May 2014June 2019

14

0 (none
related to
mobile phone
applications’
impact on
clinical
outcome or
self-care
perception).

Clinical
Practice
Guideline

May 2014June 2019

10

1 (Clinical
Practice
Guideline).

May 2014June 2019

2

0 (published
article for
screening
adults for
diabetes. 1
article for
screening for
gestational
diabetes).

______________________________________________________________________________
Levels of Evidence
The level of evidence was evaluated by using the Pyramid of Evidence by Melnyk &
Fineout-Overholt (2015). The Pyramid of Evidence is made-up of a seven-layer leveling system.
Level 1 starts at the top of the pyramid and is indicative of the highest, strongest, and most
reliable evidence. The leveling systems goes down the pyramid in succession to level II through
level VII with level VII being the weakest sources of evidence. Included in level I are systematic
reviews and meta-analysis of RCTs. Including level I evidence in an EBP practice would be
considered gold-standard, however not all themes and projects are supported by level I sources
(Melnyk & Fineout-Overholt, 2015). The fact that a study is located lower on the Hierarchy of
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Evidence does not necessarily mean that the strength of recommendation made from that and
other studies is low. When evidence shows consistency or is very compelling across studies,
strong recommendations can be made from evidence found in studies even with lower levels of
evidence (Melnyk & Fineout-Overholt, 2015). In other words, strong recommendations can be
made from lower levels of evidence, and may be sufficient in the development of an EBP project
leading toward a change in practice. Level II is just below Level I evidence on the pyramid and
this includes RCTS that have solid design and methodology. Next is level III and it is made up of
evidence from nonrandomized controlled trials. Level IV is inclusive of case-control or cohort
studies. Level V encompasses evidence from systematic review of descriptive studies and/or
qualitative studies. Level VI contains evidence from a single descriptive or qualitative study.
Finally, Level VII is comprised of evidence from expert opinions, authority opinions, or
guidelines (Melnyk & Fineout-Overholt, 2015). The Pyramid of Evidence was used as a leveling
tool to determine the strength of evidence used for this EBP project, as well as, to add clarity
and structure to the overall evaluation process. Additionally, the use of this tool demonstrates to
the reader the comprehensive hierarchical level of support for this EBP project.
Appraisal of Relevant Evidence
Appraisal of the included studies was completed through the use of the Critical Appraisal
Skills Programme (CASP) tool. This tool is not meant to replace considered thought and
judgement, but for use as a guide and to aid memory. All CASP checklists cover three main
areas: validity, results, and clinical relevance (Critical Appraisal Skills Programme, 2018). The
overall quality of the evidence body was mainly made up of systematic reviews and metaanalysis of RCTS. Additionally, 2 integrated reviews were included in the evidence, as well as, 1
clinical practice guideline. The clinical practice guideline was appraised by use of the Appraisal
of Guidelines for Research & Evaluation II (AGREE II) tool.
The CASP tool provided a clear structured path to critically appraise the studies used for
this project. The appraisal tools add an overall quality rating for each source of evidence.
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Quality rankings will be designated by using rankings of low, medium, and high. In general, 12
of the included sources of evidence received a high quality rank due to the soundness of
design, methodology, statistical analysis, and relevance to mobile phone application impact on
HbA1C and promotion of self-care practices.
Clinical practice guidelines are systematically developed statements to assist practitioner
and patient decisions about appropriate health care for specific clinical circumstances
(Brouwers et al., 2010). They play an important role in health policy formation and systemrelated decisions that include health care practice across the illness-wellness continuum.
Guidelines are only as good as their overall quality and rigor contained within the context of the
practice standard. The Appraisal of Guidelines for REsearch & Evaluation (AGREE) Instrument
was developed by an international team of guideline developers and researchers, known as the
AGREE Collaboration, and was established to create a generic instrument to assess the
process of guideline development, and the reporting of this process within the guideline
(Brouwers et al., 2010). The domain scores are useful for comparing guidelines and will inform
whether a guideline should be recommended for use to address the issue of variability in
guideline quality, and has since then been refined. This refinement has resulted in the new
AGREE II and is purposed for providing a framework to assess the quality of guidelines; provide
a methodological strategy for the development of guidelines; and inform what information and
how information ought to be reported in guidelines. Furthermore, the AGREE II assesses the
methodological rigor and transparency in which a guideline is developed. The international
consortium has not set minimum domain scores or patterns of scores across domains to
differentiate between high quality and poor quality guidelines. These decisions should be made
by the user and guided by the context in which AGREE II is being used (Brouwers et al., 2010).
After appraisal of the clinical practice guideline it was determined that it was of moderate quality
due to the lack of information in the domains of rigor and applicability.
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Level I Evidence
Systematic reviews, SRs with associated meta-analysis, meta-analysis, and evidence
summaries (Wu et al., 2017; Whitehead & Seaton, 2016; Hou, Carter, Hewitt, Francisa, &
Mayor, 2016; Cui, Wu, Mao, Wang, & Nie, 2016; Alharbi et al., 2016; Wu, Guo, & Zhang, 2019;
Pal et al., 2014; Bonoto et al., 2017; Yoshida et al,. 2018; Mann, 2018; Nguyen, 2018;
Pamaiahgari, 2018) included in this project were all level I evidence according to the Pyramid of
Evidence (Melnyk & Fineout-Overholt, 2015), and CASP quality ratings of high due to the
design and methodology of respective pieces of evidence. In all, the level and quality of the
evidence will add merit, value, and reliability to this EBP project, and shows a great amount of
support for the use of MHAs to attain glycemic efficacy, not to mention, supports the
improvement of self-care perception of T2DM patients.
Level II Evidence
The integrative reviews included in this project (Fu, McMahan, Gross, Adam, & Wyman,
2017; Wang, Xue, Huang, Huang, & Zhang, 2017) were deemed level II evidence according to
the Pyramid of Evidence, and CASP quality ratings of moderate and high respectively due to the
design and methodology of each piece of evidence. Again, this level and quality of evidence will
add merit value and reliability to this EBP project. These pieces shows support for the use of
MHAs for the reduction of HbA1C, and positive outcomes were noted related to the reaching
glycemic efficacy.
Level VII Evidence
A clinical practice guideline by Clement et al. (2018) recommended the use of telehealth
technologies, including mobile phone applications, to improve self-management in underserved
communities, facilitate consultation with specialized teams as part of a shared-care model,
improve clinical outcomes in T2DM, decrease HbA1C results, increase in quality of care,
decrease health service use and cost, increase patient satisfaction and knowledge, and
improved glycemic and cardiovascular risk factor control. The clinical practice guideline
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(Clement et al., 2018) was deemed level VII on the Pyramid of Evidence (Melnyk & FineoutOverholt, 2015), and an AGREEII quality rating of moderate due to lacking information in two of
the six domains (Brouwers et al., 2010). (See Table 2.2).
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Table 2.2
Evidence

Authors/
Purpose

Population/
Duration

Intervention(s)
/Design

Finding/
Results

LOE/
Appraisal

Alharbi et al.,
(2016)

40,454
participants.

Systematic
Review/MetaAnalysis, 32
RCTs.

HbA1C changes
with the use of
MHA and
telemedicine.

Level I

Information
technology
including mobile
phone
applications,
which
demonstrated
the largest
reduction of
HbA1C.

Resulted in a
-0.50%
reduction in
HbA1C (95%
C1).

The object of
this study was to
assess the
impact of
information
technology on
changes in the
levels of HbA1C.

Half of the
studies only
included T2DM.
The other half
included T2DM
and T1DM
Study duration
range 3-36
months.
Adults and
children.

High

MHAs and
telemedicine
analyses were
not reported
individually.

Intervention
groups received
selected types of
technology to
support diabetic
management.
Controls
received
standard
diabetic
education.
Bonoto et al.,
(2017)
The aim of the
study was to
evaluate to
efficacy of MHA
to assist the
treatment of
diabetic patients.

1.264
participants.
T1DM and
T2DM.

Systematic
Review/MetaAnalysis, 12
RCTs.

Study duration
1-2 months.

Intervention
group received
MHA to support
diabetic
management.
Controls
received
standard
education.

Adults and
children.

Use of MHAs
reduced HbA1C
by -0.44% (95%
CI).

Level I
High
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Clement et al.,
(2017)

T1DM and
T2DM.

Clinical Practice
Guideline.

Diabetes Clinical
Practice
Guideline

Adults and
Children.

109 references
were included.
Multiple
systematic
reviews and six
addressing
MHAs,
telehealth, telemonitoring, elearning,
teleconference,
website, and
internet.

Cui, Wu, Mao,
Wang & Nie
(2016)

This study aims
to describe the
usability and
clinical
effectiveness of
diabetes apps
related to
HbA1C.

Recommend
telehealth,
including MHAs
be used to
improve selfmanagement of
DM.

Level VII
Moderate

MHAs were not
endorsed over
other
technologies.

1.022
participants
T2DM.

Systematic
Review/MetaAnalysis, 13
RCTs

MHAs pooled
effect on
reduction of
HbA1C was 0.40% (95% CI).

905 participants
in the clinical
effectiveness
arm (T2DM).

Integrative
Review 19
RCTs, 1 prepost-test design

Limited evidence Level II
to support the
effectiveness of
Moderate
MHA to improve
glycemic control.

The object of
this study was to
assess the effect
of MHA on
change in
HbA1C, weight,
and lipids.0.0130.027
Fu, McMahon,
Gross, Adam, &
Wyman (2017).
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59 participants
in the usability
arm of the study.
Study duration
2-12 months.
Adults

HbA1C
reduction from
0.15% to 1.9%
(p<0.013-0.027).
Bias due to
combining other
interventions.
Subgroup
analysis not
reported.

Level I
High
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Hou, Carter,
Hewitt, Francisa,
& Mayor (2016).
The aim of this
study was to
investigate the
effect of MHAs
on HbA1C.

1,360
participants
T1DM and
T2DM.

Systematic
Review/MetaAnalysis 13
RCTs

Study duration
3-12 months.
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Evidence
indicated
reduction in
HbA1C use and
MHA was 0.49%
(95% CI).

Level I
High

After excluding
subgroups of
poor findings,
HbA1C
reduction was
0.41% (95% CI).
Poor findings
were studies
with a reduction
higher than
expected, which
questioned
legitimacy of the
findings.

Adults and
Children

Ten studies of
T2DM resulted
in consistent
0.50% HbA1C
reduction (95%
CI).
Mann, E. (2018).

65,456
participants
To determine
T1DM and
the effectiveness T2DM.
of selfmanagement
Study duration
education for
6-12 months.
those with DM.
Adults and
Children.

Evidence
Summary.

Nguyen, P.
(2018).

Evidence
Summary

To determine
the best
evidence
regarding self-

3,783
participants
T2DM.
Study duration
3-12 months.

Those with DM
should receive
education that
includes taking
medications,
monitoring
glucose, and
problem-solving.

Level I
High

Education
included selfmanagement
with MHAs

Self-monitoring
of blood glucose
is an integral
part of DM
management.
MHA research
supported in the

Level I
High
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monitoring of
blood glucose.

Pal, et al.,
(2014).
This study
aimed to
evaluate the
impact of
computer-based
DM selfmanagement
interventions of
health status
and quality of
life.

Pamaiahgari, P.
(2018).

27
body of
evidence that
was foundational
for this summary

3,578
participants
T2DM.
Study duration
10 minutes – 18
months.
Adults

Systematic
Review/MetaAnalysis, 16
RCTs.
Intervention
included MHAs,
clinic education,
and internet.

Mobile phone
subgroup had
the largest effect
on glucose
control,
compared to
other computerbased
intervention.
Pooled effect for
this mobile
phone subgroup
was an HbA1C
reduction of
0.50% (95% CI).

Level I
High

8,124
participants
T1DM and
T2DM.

Evidence
Summary

Best practice
Level I
recommends
that mobileHigh
based support
programs should
be considered in
the management
of DM in a rural
or remote
setting.

Wang, Xue,
Huang, Huang &
Zhang (2017).

2.029
participants
obese or T2DM.

Integrative
review 16 RCTs,
8 Quasiexperiments.

Level II

The aim of this
study was to
determine the
effectiveness of
mobile devices
on technology
interventions on
obesity and DM.

Study duration 1
week – 24
months.

MHA subgroup
resulted in a
reduction with
HbA1C, with the
greatest 1.0%
(p,0.001).

Whitehead &
Seaton (2016)

Sample size
range 48-288
participants.
T1DM and
T2DM.

Systematic
Significant
Review, 9 RCTs. improvement
relating to the
reduction of
HbA1C in four of
five studies.

Level 1

To determine
the best
evidence for the Study duration
use of eHealth in 3-12 months.
the management
of DM.
Adults and
Children.

This study was
conducted to
assess the

Adults

Included MHAs,
text messages,
and portable
monitoring
devices.

High

High
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effectiveness of
MHA on DM.

Study duration 6
weeks – 12
months.

Improvement
was found to be
statistically
significant.

Adults and
children.

Wu et al.,
(2017).
The aim of this
study was to
develop and
validate
taxonomy,
investigate
glycemic control,
and explore
contributions of
different MHA
functions related
to the reduction
of HbA1C.

974 participants
T1DM and
T2DM
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Results were
HbA1C
reduction of
0.40% (p <
0.019) to 1.9 (p
< 0.001).
Systematic
Review, 12
RCTs.

Study duration
3-12 months.
Adults and
Children.

MHAs were
associated with
a clinically
significant
reduction of
HbA1C 0.48 %
(95% CI). No
excessive
adverse effects
noted.

Level I
High

Larger
reductions of
HbA1C were in
T2DM group.
Having a
complication
prevention
module in the
MHA was
associated with
a greater
reduction 1.13%
(95% CI) versus
without.
Inclusion of
clinical decision
function did not
reduce HbA1C.

Wu, Guo, &
Zhang (2019).
This study
aimed to
synthesize the
clinical evidence

2.526
participants
T1DM and
T2DM.
Study durations
3-12 months.

Systematic
Review, 26
RCTs. 11
specific to
T2DM.

Use of MHA
showed an
HbA1C
reduction of
0.48% (95% CI).

Level I
High
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of the efficacy of
MHAs for
lifestyle
modification in
different
diabetes
subgroups.

Yoshida et al.,
(2018).
This study
aimed to
determine the
effect of HIT on
HbA1C.

29
Strong evidence
for the efficacy
of MHAs for
lifestyle
modification in
T2DM. Evidence
inconclusive for
other diabetes
subgroups.

3.982
participants
T2DM.
Study duration
2-12 months.

Meta-analysis,
34 RCTs. 29
specific to
T2DM.
HIT included
mobile phone,
web-based,
short message
text, telephone,
and video
conference.

HbA1C
reduction due to
health
information
technology (HIT)
were found
across all
studies.

Level I
High

MHAs had
greatest pooled
HbA1C
reduction of
-0.67% (95%
CI). MHAs
produced largest
reduction effect.
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Synthesis of Critically Appraised Literature
Technology
Mobile health applications. The use of MHAs have been found to be the most
effective tool to promote self-care behaviors that reduce overall HbA1C levels. The reduction of
HbA1C have been found in other means of diabetic self-management technologies, but MHAs
proved to have the greatest reduction pattern (Pal, et al., 2014; Pamaiahgari, 2018; Cui, Wu,
Mao, Wang, & Nie, 2016; Hou, Carter, Hewitt, Francisa, & Mayor, 2016; Wang, Xue, Huang,
Huang, & Zhang, 2017; Wu et al., 2017; Whitehead & Seaton, 2016; Yoshida et al., 2018).
Within in the literature it was noted that all individuals with diabetes should have diabetic
education that includes topics such as healthy diet, being physically active, taking medication,
and monitoring glucose (Mann, 2018; ADA, 2018). Nguyen (2018), indicates that a structured
self-monitoring of blood glucose is more beneficial than non-structured. MHAs support the ADA
(2018) recommendations that lead to improved HbA1C levels. Another systematic review found
that HbA1C decreased more in the MHA-only group than in the control or group that received
counseling as an intervention (Whitehead & Seaton, 2016). Overall, findings in the literature
point to the use of MHAs for best practice toward efforts to reduce HbA1C levels compared to
other forms of technology. Moreover, MHAs appeared to be moderately effective in promoting
lifestyle changes, including daily physical activity and medication adherence (Cui, Wu, Mao,
Wang, & Nie, 2016).
Computer-based. In one study, computer-based or internet-based interventions to
manage T2DM were shown to have a small benefit on HbA1Cs, but less than the MHA
subgroup (Pal, et al., 2014). Computer-based intervention was also supported by an additional
systematic review, however in that study the effect of MHAs on HbA1C levels resulted in a
0.40% reduction compared to a 0.2% reduction in the computer-based arm (Cui, Wu, Mao,
Wang, & Nie, 2016). Yoshida et a. (2018) found that a computer-based intervention decreased
HbA1C, however, in comparison MHAs produced a larger effect. Although MHA use has shown
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to produce a greater decrease in HbA1C, where mobile-based programs are not available,
computer-based programs should be considered for the management of T2DM (Pamaiahgari,
2018).
Text messaging. Text messaging was another form of technology that was identified in
the literature (Wang, Xue, Huang, Huang, & Zhang, 2017; Yoshida et al., 2018). Text
messaging was mainly used to provide knowledge and tips on diet, physical activity, and
medications, whereas the MHA played a more concise role in disease control by providing
feedback to reinforce positive behavior changes as well as serving as a data collection platform
(Wang, Xue, Huang, Huang, & Zhang, 2017). The findings by researchers Wang, Xue, Huang,
Huang, and Zhang (2017), that focused on T2DM indicated the greatest HbA1C reduction was a
result of the use of MHAs rather than text messaging. Yoshida et al. (2018) found that text
messaging decreased HbA1C, however, in comparison MHAs produced a larger effect.
Voice messaging. Voice messaging through use of automated services, interactivevoice systems, teleconferencing, and telephone-based services were also compared to MHAs.
Researchers (Alharbi et al., 2016; Bonoto et al., 2017; Cui, Wu, Mai, Wang, and Nie, 2016; Wu,
Guo, and Zhang, 2019; Wu et al., 2017; Wang, Xue, Huang, Huang, Zhang, 2017; Yoshida et
al., 2018) found that MHAs produced a larger reduction in HgA1C compared to these various
voice messaging interventions. MHAs used in the studies (Alharbi et al., 2016; Bonoto et al.,
2017; Cui, Wu, Mai, Wang, and Nie, 2016; Wu, Guo, and Zhang, 2019; Wu et al., 2017; Wang,
Xue, Huang, Huang, Zhang, 2017; Yoshida et al., 2018). included functions that were geared
toward fostering behavioral lifestyle modifications to improve self-care management of T2DM.
This was a feature not available through typical voice messaging systems (Alharbi et al., 2016;
Bonoto et al., 2017; Cui, Wu, Mai, Wang, and Nie, 2016; Wu, Guo, and Zhang, 2019; Wu et al.,
2017; Wang, Xue, Huang, Huang, Zhang, 2017; Yoshida et al., 2018).
Telehealth services. Telemedicine, telehealth, Video-phone chat, interactive-video
systems, were compared to MHAs throughout the literature. Researchers found that the MHAs
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demonstrated the largest reduction in HbA1C. Use of MHAs brought the greatest standardized
decrease in HbA1C and produced the largest effect on glycemic control (Cui, Wu, Mai, Wang,
and Nie, 2016; Wang, Xue, Huang, Huang, Zhang, 2017; Alharbi et al., 2016; Yoshida et al.,
2018).
Technology used for diabetes self-management exists in the form of many different
platforms, such as internet, telemedicine, teleconference, mobile phone SMS (texting),
computer-based programs, and MHAs. Throughout the evidence used to develop this project,
the use of MHAs showed a statistically significant reduction in HbA1C reduction (Alharbi et al.,
2016; Bonoto et al., 2017; Cui, Wu, Mao, Wang, & Nie, 2016; Hou, Carter, Hewitt, Francisa, &
Mayor, 2016; Pal et al., 2014; Wang, Xue, Huang, Huang, & Zhang, 2017; Whitehead & Seaton,
2016; Wu, Guo, & Zhang, 2019; Wu et al., 2017; Yoshida et al., 2018).
Outcomes
Glycemic Efficacy
Glycemic control was consistently measured through HbA1C measurements throughout
the literature, and is defined as a HbA1C level of less than 8.0 (ADA, 2018). The ADA (2018)
suggests a more stringent HbA1C goal of < 6.5% if the patient can achieve this without
significant hypoglycemia or adverse effects, and a less stringent goal of <8% if the patient has
a history of hypoglycemia, limited life expectancy, long-standing diabetes, appropriate glucose
monitoring, and effective doses of glucose lowering agents. For the purpose of this project and
to err on the side of safety, the project will utilize the less stringent HbA1C goal of <8.0%.
HbA1C is a significant indicator because it reflects glycemia over eight weeks of time (Alharbi et
al., 2016), and has a strong correlation in the occurrence of diabetic complications and
increased mortality rates in people with diabetes (Bonoto et al., 2017; Yoshida et al.,
2018). Glycemic control was statistically significant across most of the body of evidence that
was included in the EBP project (Alharbi et al., 2016; Bonoto et al., 2017; Clement et al., 2018;
Cui, Wu, Mao, Wang & Nie, 2016; Hou, Carter, Hewitt, Francisa, & Mayor, 2016; Nguyen, 2018;
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Pal et al,. 2014; Pamaiahgari, 2018; Wang, Xue, Huang, Huang, & Zhang, 2017; Whitehead &
Seaton, 2016; Wu et al., 2017; Wu, Guo, & Zhang, 2019; Yoshida et al., 2018). The exception
was the limited evidence reported by Fu, McMahon, Gross, Adam, & Wyman (2017), the
findings of which were believed to be due to confounding variables that infused the results with
bias. However, HbA1C reduction was still found by the researcher, but were not statistically
significant.
Alharbi et al. (2016) conducted a systematic review of 30 RCTs and concluded that by
using MHAs, telemedicine, web-based, and telephone-based interventions, participants
achieved significant reduction in HbA1C. T2DM participants that used these electronic selfmanagement technologies found the greatest impact on HbA1C reduction, which resulted in a 0.50% reduction of HbA1C (95% CI). Subgroup analysis was not included in this study so it is
not clear which specific technologies had the greatest effect. Bonoto et al. (2017) concluded that
the use of MHAs by adult T2DM participants could help improve the control of HbA1C. Of the 13
RCTs included in their study, six of them produced statistically significant reductions in HbA1C
values. The meta-analysis of those studies resulted in a mean HbA1C reduction difference of 0.44 (CI -0.59 to 0.29 p < 0.001). Cui et al. (2016) concluded that there was a moderate effect
on glycemic control after the mHealth app-based interventions. The overall effect on HbA1C
showed a mean reduction difference of -0.40% (-4. 37 mmol/mol) (95% CI -0.69 to -0.11 p =
0.007) and the standardized mean difference was -0.40 % (-4.37 mmol/mol) (95% CI -0.69 to 0.10% p = 0.008). Fu et al. (2017) concluded that MHAs that were used in the studies of their
review reduced HbA1C, ranging from 0.15-1.9% from baseline. Statistical significance was
found in four of the studies within the integrative review. The greatest interactive features were
those included the application’s design and consisted of MHA used in conjunction with a
Bluetooth® enabled smart-glucometer, direct provider feedback capability, and website access.
Hou et al. (2016) found that in all of the studies in their review, mean reduction of HbA1C was
0.49% (95% CI 0.30, 0.68 p = <0.01). These results exhibited consistent findings with no
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heterogeneity. After excluding subgroups of skewed findings, a mean reduction of 0.41% was
found (95% CI 0.22, 0.61; p <0.001 I=0%). An example of a subgroup study with skewed
findings that was excluded, was one that found a significantly higher reduction in HbA1C than
any of the other studies included in the review. The researchers (Hou et al., 2016) concluded
that the applications improved self-management by providing personalized feedback on selfmonitoring data such as blood glucose, food intake, and physical activity. Additionally, the use
of the MHAs resulted in decreased consultation times. Pal et al. (2014) concluded that the
mobile phone subgroup had the largest effect on glycemic control compared to the other
computer-based self-management interventions. Pooled effect for this subgroup was a HbA1C
reduction of -0.50% (95% CI -0.7% to -0.3%). There was no evident improvement in depression,
quality of life, blood pressure, serum lipids, or weight in this study. Pamaiahgari’s (2018) best
practice recommendations indicate that mobile-based support programs, including MHAs,
should be considered in the management of diabetic patients where available. Where mobilebased programs are unavailable, computer-based programs should be considered. The review
by Wang et al. (2017) included five studies that used MHAs, which resulted in a reduction in
HbA1C with the largest reduction being 1.0% at a 12-month follow up period. Whitehead et al.
(2016) concluded statistically significant improvements in the reduction of HbA1C in two of the
three studies included in their review that specifically focused on T2DM participants (-0.40 p =
0.019, -1.9% p = 0.001). Moreover, the use of MHAs has the potential to improve health
outcomes among those living with chronic diseases such as T2DM. Wu, Guo, & Zhang (2019)
concluded that there is strong evidence for the efficacy of mobile phone applications for lifestyle
modification in type 2 diabetes. This systematic review and meta-analysis conducted a
subgroup analysis specific to adult T2DM participants. In the short-term effect group that
showed virtually no heterogeneity, the MHAs group produced a -0.48 ( 95% CI -0.69 to -0.28)
reduction in HbA1C. In the long-term group HbA1C reduction was -0.25 (95% CI -0.43 to -0.07)
and both groups resulted in statistically significant reduction in HbA1C. The results were
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inconclusive for the other diabetes subtypes. Wu et al. (2017) researchers concluded that using
MHA interventions were associated with a clinically significant reduction of HbA1C with a mean
difference of 0.48% (95% CI 0.19%-0.78%) without excess adverse events. The larger
reductions of HbA1C were found among patients with T2DM. Having a complication prevention
module in app-based interventions was associated with a greater HA1C reduction (MD 1.31%,
95% CI 0.66%-1.96%) versus without. Yoshida et al. (2018) completed a systematic review that
included 16 RCTs and eight quasi-experiments and they found the overall reduction effect was 0.63. MHAs had the greatest pooled standardized decrease in HbA1c reduction of -0.67 (-0.90,
- 0.45). On average, MHA interventions produced larger effects compared to other forms of
approaches. These researchers concluded that the findings from the meta-analysis suggest that
health information technology, including MHAs, led to improvement of glycemic control.
Self-Care Behaviors
The ADA (2018) speaks to reaching glycemic efficacy through self-care behaviors such
as monitoring blood sugars, physical activity engagement, and adherence to prescribed
medications for those who suffer from chronic diseases such as diabetes. Cui, Wu, Mao, Wang,
& Nie (2016) concluded that MHAs offer moderate benefits to T2DM self-management. These
researchers recommended a follow up period of greater than 12 months to evaluate the longterm impact of MHAs for diabetes care and self-management. Mann (2018) determined best
practice recommendations indicate that all individuals with diabetes should receive selfmanagement education that includes topics such as healthy diet, being physically active, taking
medication, monitoring of glucose, reducing risk and complications, and problem solving. Selfmanagement education is recommended through the use of MHAs (Pamaiahgari, 2018; Wu,
Guo, & Zhang, 2019; Wu et al., 2017). Nguyen (2018) indicated that self-monitoring is
recommended as an integral part of diabetes self-management strategies. This evidence
summary included a meta-analysis of RCTS in which the researchers found that compared to
those who did not perform self-managed blood glucose (SMBG), individuals who performed
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SMBG reduced HbA1C level by 0.17% (95% CI 0.25 to 0.09%, p <0.003). The comparison
between structured and unstructured SMBG found a mean difference of HbA1C reduction of
0.27% (95% CI 0.49 to 0.04%, p < 0.018). The conclusion favored structured SMBG which
indicated a structured SMBG was found to be more beneficial than non-structured SMBG.
Structured SMBG consisted of scheduled monitoring and recording of blood glucose for tracking
and evaluation purposes. (Mannucci, Antenore, Giorgino, & Scavini, 2018). MHAs have
provided a structured-electronic platform for the monitoring and recording of blood glucose in
adults with T2DM that leads to improved glycemic control.
MHAs that have the greatest interactive features which encourage blood glucose
monitoring, physical activity engagement, and adherence to medication regimens are directly
related to improvements in glycemic control glycemic control (Pal et al., 2014; Fu, McMahon,
Gross, Adam, & Wyman, 2017; Mann, 2018; Nguyen, 2018). This provides a convenient
reminder and documentation system that is more accurate then depending on memory alone.
Pamaiahgari (2018) produced an evidence summary that recommended mobile-based support
programs should be considered in the management of diabetic patients. Mobile-phone based
interventions (including MHAs) were included in this recommendation. Other researchers have
found that mobile phone interventions for diabetes self-management have been able to reduce
HbA1C levels, and this may be related to the enhanced feedback and provider-patient
interactions, the convenience of the MHA usage, the intensity of the intervention, or the
behavior-change techniques instilled in the applications. Behavioral reminders through the use
of MHAs encourage blood sugar monitoring efforts and improve physical activity engagement
(Cui, Wu, Mao, Wang, & Nie, 2016; Wu et al., 2017; Wu, Guo, & Zhang, 2019; Yoshida et al.,
2018; MyFitnessPal, 2019). Also included in the MHAs were behavior-change techniques or
reminders to promote adherence to medication regimens. The use of MHAs interventions have
suggested a moderate effect in promoting lifestyle changes, including daily physical activity and
medication regimen adherence (Cui, Wu, Mao, Wang, & Nie, 2016; Clement et al., 2018; Hou,
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Carter, Hewitt, Francisa, & Mayor, 2016; Pamaiahgari, 2018; Wang, Xue, Huang, Huang, &
Zhang, 2017; Wu et al., 2017; Wu, Guo, & Zhang, 2019; Yoshida et al., 2018).
Self-Care Perception
MHA’s had a mixed impact on self-care perception for adults with T2DM (Bonoto et al.,
2017; Pal et al., 2014; Wu, Guo, & Zhang, 2019). Bonoto et al. (2017) found that MHAs seem to
strengthen the perception of self-care by contributing better information and health education to
the patient that ultimately boosts self-confidence to care for this devastating disease. Ultimately,
self-confidence in personal care may support self-care behaviors for those with chronic
diseases Bonoto et al. (2017) measured this using the Disease-Specific, Quality-of-Life
(DSQOL), Diabetes Quality of Life (DQOL), Diabetes Quality of Life for Youth (DQOLY) and
Self-Care Revised 36-item Short-Form. Pal et al. (2014) found there was no evident
improvement in self-care perception and various tools to measure this were not mentioned.
Improved self-care perception was found to be strengthened by the MHAs ability to contribute to
better information and health education, increased patient satisfaction, and increased selfconfidence to the user (Bonoto et al., 2017; Clement et al., 2018; Wu, Guo, & Zhang, 2019).
Best Practice Model Recommendation
Best practice recommendations include a multi-functional, user-friendly MHA that is
adaptable to the feedback of the provider (Wu et al., 2017; Nguyen, 2018; Mann, 2018; Fu,
McMahon, Gross, Adam, & Wyman, 2017). Provider feedback included the use of MHAs, webbased, computer-based, and telephone-based interventions. The iHealth® and Dario® smart
glucometer bundles offer a mobile smartphone application that allows for individualized patientprovider selected alert settings for reminders to check blood sugar, take medication, and
engage in activity. Additionally, these bundles include a smart glucometer that pairs with mobile
smartphone technology for convenient uploading and downloading of glucose readings, physical
activity, and medication adherence practices (Dario® Blood Glucose Management System,
2019; iHealth® Smart Wireless Gluco-Monitoring System, 2019). Moreover, the addition of a
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MHA shows an improvement in the perception of self-care management behaviors such as
blood glucose monitoring efforts, medication adherence, and physical activity engagement of
adults with T2DM.
Three options of MHAs were considered for this EBP. Regardless of the MHA selected it
will include glucose monitoring capability, physical activity monitoring , and medication
adherence monitoring. Notification alert reminders for blood sugar monitoring, medication
adherence and physical activity engagement will be patient-driven and individualized according
to the specific need of each participant in regards to these activities. The overall functionality
options of the MHA, provider feedback loop of communication, and the promotion of self-care
practices can foster glycemic control and theoretically reduce incidence of diabetic complication
and decreased mortality (Alharbi et al., 2016; Bonoto et al., 2017; Clement et al., 2018; Cui, Wu,
Mao, Wang, & Nie, 2016; Fu, McMahon, Gross, Adam, & Wyman, 2017; Hou, Carter, Hewitt,
Francisa, & Mayor, 2016; Mann, 2018; Nguyen, 2018; Pal et al,. 2014; Pamaiahgari, 2018;
Wang, Xue, Huang, Huang, & Zhang, 2017; Whitehead & Seaton, 2016; Wu et al., 2017; Wu,
Guo, & Zhang, 2019; Yoshida et al., 2018). The use of MHAs may also result in improved selfcare perception which may also contribute to improved self-care practices such as blood sugar
monitoring efforts, adherence to medication regimens, and physical activity engagement.

Mobile Application for Glycemic Control

39
CHAPTER 3

IMPLEMENTATION OF PRACTICE CHANGE
The purpose of the EBP project was to evaluate the effectiveness of a diabetes-specific
MHA on HbA1C and on self-care behaviors such as blood glucose monitoring efforts, physical
activity engagement, and medication adherence. A secondary purpose of the EBP project was
to evaluate cumulative self-care perception before and after the intervention. The
implementation of EBP to drive practice changes is a challenging process and needs to
strategically address organizational complexities, administrative leaders, clinicians, and
ultimately the healthcare culture (Titler, 2001). Quality outcomes and positive patient
experiences are demanded by consumers, required by payees, and transparently reported to
the public (Creehan, 2015). Healthcare is changing at a rapid pace and the diffusion of evidence
into practice is essential as the shift in quality and safety practices become the focus throughout
all health organizations. This dynamic movement is not new and is becoming increasingly
urgent as challenges related to both quality and cost persist (Bondurant & Armstrong, 2016).
Doctorally prepared nurses are uniquely skilled and highly qualified to change practice by
improving quality and safety and decreasing cost burden through the implementation of EBP.
Setting and Participants
Setting
The EBP project was conducted at certified rural healthcare centers in northwest
Indiana. The medical group consists of 13 primary healthcare providers. Six of the primary care
providers are medical doctors and seven are family nurse practitioners. Five of the medical
doctors are employed at the Winamac, Indiana location, while one is located at the North
Judson, Indiana location. Four nurse practitioners are employed at the Winamac, Indiana
location, while one is employed at each of the satellite offices in northwest Indiana. All of the
providers provide care for patients with T2DM that fall within the inclusion criteria for this project.
The project preceptor is the director of quality and compliance for the organization. She was
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selected due to her expertise in quality and safety reporting that is mandatory when an
organization accepts payment from the Centers of Medicare and Medicaid Services (CMS,
2019) (M. Jones, personal communication, May 24, 2019). She has an associate’s degree in
business administration, and has been employed with the organization for eight years. She has
direct access to the EMR driven quality measures and was able to obtain the CMS specific
outcome measures that indicated a high percentage of patients with HbA1C above 9.0.
The MHA project was led by a doctor of nursing practice (DNP) student who has a board
certification as a Family Nurse Practitioner. Her career encompasses 28 years of nursing
experience, which included a special interest in the management of adults with T2DM. The DNP
student led the MHA pilot program with the assistance of two additional nurse practitioner
champions, a project preceptor, and a corporate compliance/quality assurance leader. The
project preceptor and the DNP student had initial meetings early on to determine the greatest,
most pressing organizational need. Consultations were continuously made within the group to
brainstorm and determine the best direction for the practice change. Practice champions
included two nurse practitioners who have agreed to assist with the creation and implementation
of the protocol (See Appendix A). The lead nurse practitioner at the healthcare center in
Monterey, Indiana has been employed in family practice for 11 years. He completed his
education at Valparaiso University and is a master’s prepared, board certified family nurse
practitioner. The healthcare center is a rural satellite primary care practice that strives to offer
high quality care to the local and surrounding communities. Additionally, the nurse practitioner of
this clinic is a veteran who proudly served in the Army. He has been a nurse for over 20 years
and has special interest in pain management and management of adults with T2DM.
A nurse practitioner at the Winamac healthcare center completed her education at
Indiana State University, and is a master’s prepared, board certified family nurse practitioner.
She has been employed as a family nurse practitioner in primary care for 3 years and strives to
offer high quality care to the local and surrounding communities. She has been a nurse for over
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20 years and has special interests in women’s health services and management of adult T2DM
patients.
Participants
The focus population was English reading and speaking patients that are 18 years and
older within the organization’s medical group diagnosed with T2DM, having an HbA1C of
greater than 8.0, and owners of a smart phone. Generally, middle aged individuals are more
likely to have T2DM, but it has been found in obese children (ADA, 2018). For this project
pregnant women and children were excluded, as well as those who did not own or have access
to a mobile smart phone or tablet. Additionally, patients with dementia, addictions, or other
mentally or physically incapacitating medical conditions were excluded.
Pre-Intervention Group Characteristics. Demographic data were collected and
recorded (See Appendix B) at a special initial start-up meeting using the participant information
sheet (See Appendix C) to collect the participant’s age, date of birth, gender, race, years
diagnosed with T2DM, current diabetes-specific medication, how often they normally engaged in
physical activity, the email address of their provider, pre-intervention HbA1C, and their personal
email address. This information will be used to assess the characteristics of the project sample
to that of the adult T2DM in the general population. Twenty-five participants joined the project
and seven were lost to attrition. The mean age for the group was 52.2 years made up of five
white males and 13 white females, and mean number of years of having the diagnosis of T2DM
was 12.72.
Intervention
The intervention consists of the use of a diabetes-specific MHA for the self-management
of T2DM. The EBP practice program developed is called Living Sweet: An Adult Type II
Diabetes Mellitus Management Program. The project will utilize a MHA platform to deliver selfcare behavior awareness toward the promotion glycemic control. The application selection
process was a challenge due to the many different functionality qualities of the various

Mobile Application for Glycemic Control

42

applications. For instance, most of them allow for logging blood sugar readings, recording
physical activity events, and medication adherence trackers (MySugr®, 2019; Health2Sync®,
2019; Diabetes Connect®, 2019). Multiple applications were evaluated for this project, however
the one that was the most user friendly, cost-effective, technologically equipped, and aligned
with ADA diabetes mellitus self-management recommendations was selected (ADA, 2018)
The diabetes-specific MHA utilized for this project is MySugr®. The attractions of
MySugr® diabetes-specific mobile health application is that it is cost-efficient, user-friendly,
capable of monitoring the three different self-care behaviors that were evaluated in this project,
Android® and iPhone® compatible, congruent with ADA (2018) self-management
recommendations, and has the capability to upload and transfer or export the documented
results electronically as a spreadsheet (MySugr®, 2019). In some cases, MHAs may not be
advantageous for certain participants such as those with learning deficits (Fu, McMahon, Gross,
Adam, & Wyman, 2017). To enhance usability for these participants, access to the DNP student
project leader or designee will be offered throughout the entire project time span. The MHA will
be used as a reminder system that will include patient-centered, individualized goals to
encourage self-care behaviors such as blood glucose monitoring efforts, medication adherence,
and physical activity engagement. Adherence will be assessed by determining the total number
of met self-care behaviors each week.
Each participant was given a one-on-one enrollee learning session by the DNP student
project leader. This session included a review of the participant information sheet (See
Appendix C) education and demonstrations regarding the use of the MHA, as well as discussion
about individual personal self-care behavior goals. In Addition, a pre-intervention self-care
inventory-revised tool (See Appendix D) was completed to record self-care perception prior to
the onset of using the MHA. This will help determine the impact of the intervention of participant
self-care perception.
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Due to the nature of the sensitive information being discussed, 1-on-1 sessions were
more fitting to minimize potential discomfort that may accompany a group setting. This session
will allow participants to meet and build rapport with the DNP student project leader, received
clear explanation of the program, allow for question and answer opportunities, obtain
demographic information, complete the initial self-care revised-inventory tool, and determine
personal goals for blood glucose monitoring efforts, physical activity engagement, and
medication adherence.
One challenge noted during the process was that the phones of participants were not
current with phone updates. This resulted in the DNP student spending extra time assisting with
the updating of the smart phones. This prompted a verbal reminder to each participant to update
the operating system of their phone prior to the initial startup meeting. Additionally, this step was
added to the protocol. In many cases participants could not remember the password that was
connected to their smart phone application store. This was imperative, because without the
password the application could not be downloaded. This certainly slowed the initiation process
considerably and a prompt was added to the protocol to remind users to be aware of the
password to their phones prior to the initial setup date. In one case a participant did not own a
smart phone, however she did own an Android© tablet which worked identical to the smart
phone application. An isolated challenge included a participant that did not have an email
address or password to her email. This is important when downloading applications because the
personal email is used by the application to verify the identity of the person wanting to place it
on their smart phone. There was a significant delay in the startup process for this participant
because she had to connect with her daughter who set up the initial email and password for her
smart phone. Again, a prompt was added to the protocol to remind users to be aware of the
username and password to their personal email for verification purposes.
The program included a tracking form with built-in check points (See Appendix E) to
determine if the participant has any questions or needs assistance troubleshooting the
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application. These check points will occur at week 1, week 2, week 3, week 4, week 5, week 6,
and week 7 to determine adherence and need for assistance and troubleshooting of the
application (see Table 3.1). Check points and data exportation will occur on different dates for
each participant due to staggered start to the program. Therefore, to direct participants to meet
the weekly data exportation request to the DNP project leader and their respective primary care
provider, reminders were written on a pre-printed calendar (See Appendix F) and given to each
of them. During this time each participant has been instructed to electronically upload and
export their recorded data to the DNP student project leader and primary care provider when
applicable. In the event the DNP student project leader has not received exported data from a
participant or participants at these designated time-frames or has missing data, a text or phone
call will be completed. The scheduled check points will help to further guide and define the MHA
program by heightening awareness of unforeseen barriers and variables that may deter
adherence. Week 8 will be the completion of the program and includes an arranged meeting
with the project leader. At this time a patient satisfaction survey (See Appendix G), a repeat selfcare inventory-revised tool (See Appendix D), and a post-intervention HbA1C will be completed
to evaluate impact of MHAs on selected outcome measures. The potential benefits of the MHA
program include HbA1C reduction, improved self-care behaviors, and improved self-care
perception. Risks were not associated with the use of MHAs. However, lack of experience with
technology and learning deficits may hinder the use of the application for some participants (Fu,
McMahan, Gross, Adam, & Wyman, 2017).
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Table 3.1
Diabetes-specific MHA Program Outline
Check Point

Topic

Initial
(Special Session)

Program introduction.
Document most recent HbA1C.
Intervention education.
Self-Care Inventory-Revised: Pre.
Patient-driven goal determination
of self-care behaviors entered into the app.
Review participant information sheet.

Check Point 1
(Week 1)

Assess adherence based on patient upload
data. Troubleshoot.

Check Point 2
(Week 2)

Assess adherence based on patient upload
data. Troubleshoot.

Check Point 3
(Week 3)

Assess adherence based on patient upload
data. Troubleshoot.

Check Point 4
(Week 4)

Assess adherence based on patient upload
data. Troubleshoot.

Check Point 5
(Week 5)

Assess adherence based on patient upload
data. Troubleshoot.

Check Point 6
(Week 6)

Assess adherence based on patient upload
data. Troubleshoot.

Check Point 7
(Week 7)

Assess adherence based on patient upload
data. Troubleshoot.

Check Point 8
(Week 8)

Satisfaction Survey
Self-Care Inventory-Revised: Post
Obtain HbA1C: Post
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Comparison
The high percentage of HbA1C results greater than 9.0 within the medical group was the
motivation for this project. In Quarter 1 of 2019, 59.3% of adult T2DM patients had an HbA1C
greater than 9.0, and this trend rose in the second quarter to 66%. The outcome measure of 9.0
is specifically requested by and reported to CMS as a quality indicator, and the medical group
are not meeting the standard risking loss of reimbursement for services (CMS, 2019).
Outcomes
Two major outcomes were evaluated for the diabetes-specific MHA intervention: (a)
effect on HbA1C levels, and (b) effect on self-care behaviors. For this project, glycemic control
is measured through obtaining HbA1C by capillary blood tests comparing individuals’ results to
prior test result to results after an 8-week MHA intervention. The statistical test used to evaluate
the HbA1Cs was the paired t-test which is used to determine if the pre-intervention mean results
are significantly different from the post-intervention mean results. The paired sample t-test,
sometimes called the dependent sample t-test, is a statistical method used to determine
whether the mean difference between two sets of observations is zero. In a paired sample t-test,
each subject or entity is measured twice, resulting in pairs of observations (Statistic Solutions,
2019). Frequency analysis expressed in percentage was used to examine weekly self-care
behaviors goals that were met or not met (Statistic Solutions, 2019). Self-care behaviors will be
evaluated based on self-selected individualized goals chosen by each participant. Individualized
goal assessments will determine if the participant met or did not meet blood sugar monitoring,
medication adherence, and physical activity engagement. A behavior tracking form was created
to monitor individualized weekly self-care behavior goals (See Appendix H). Glucose
monitoring, medication adherence, and physical activity were considered met if the participant
recorded 100% of their self-selected goals, and not met if the participant recorded less than
100% of their expected goals. As participants complete the self-care behaviors monitored in this
project, then will be record results through manual data entry by tapping an icon specific to
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medications, blood glucose monitoring, and physical activity within the MHA. This information
will then be digitally exported to the DNP student project leader’s and participant primary care
provider’s email for review.
Self-care perception with use of MHAs were collected using the Self-Care InventoryRevised (SCI-R) tool (See Appendix D) completed before and after an 8-week MHA
intervention. The SCI-R is a psychometrically sound measure of perceptions of adherence to
recommended self-care behaviors of adults with T1 and T2DM (Weinger, Welch, Butler, & La
Greca, 2005). The tool is a Likert-scale survey that allows for self-assessment of diabetes selfcare behaviors (Weinger, Welch, Butler, & La Greca, 2005). Through self-reporting what each
participant achieves regarding diabetes-specific self-care behaviors over the previous 1-2
months. Scoring of the survey quantifies reported behaviors in the following fashion: never = 1,
rarely = 2, sometimes = 3, usually = 4, and always = 5. This tool was found to have sound
reliability and validity through a psychometric analysis and reflects the internal consistency of
the SCI-R tool (α = 0.87). Correlation with a measure of frequency of diabetes self-care
behaviors r = 0.63 supports concurrent validity of the SCI-R (Weinger, Welch, Butler, & La
Greca, 2005). The statistical method that was used to evaluate pre- and post-SCI-R tool results
was the paired sample t-test (Cronk, 2018).
Time
Prior to the launch of this EBP project, three Power Point presentations were given to
medical staff with a provider-specific information sheet (See Appendix I) to highlight project
details and clarify the referral process. Following the EMR-directed referral (See Appendix J), a
retrospective search of the referred participants within the EMR was completed to ensure
participants met inclusion criteria. After inclusion criteria were confirmed, each participant was
contacted, and a special meeting was arranged to initiate the MHA program. During this special
meeting, a participant information sheet (See Appendix C) that clearly explains the program was
reviewed, a pre-intervention SCI-R was completed, and the MHA was downloaded to each
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participant’s mobile phone. Respective forms were developed to facilitate the introduction of the
MHA program and keep the process consistent and reproducible. The implementation began on
September 6, 2019. Successful completion consisted of being enrolled for 8 weeks of MHA
usage and completing the post- intervention HbA1C, SCI-R, and satisfaction survey.
Participants remained in the same cohort, in a staggered start-up arrangement. To ensure each
participant will receive 8-weeks of MHA usage, the final participant was enrolled by October 30,
2019. Participants may stop using the MHA at any time without recourse. Those who did not
complete at least 1 week of usage will be excluded from statistical evaluation. The plan is to
enroll 25 participants in the launch of this pilot EBP project, in hopes to have 20 participants
complete the 8-week program.
The final meeting included a satisfaction survey (See Appendix G) related to the
enrollment into the MHA program and a post-intervention Self-Care Revised-Inventory tool,
which was completed by December 31, 2019. The satisfaction survey provides significant
information about positive and negative experiences of the MHA program. These reported
experiences are critical when developing a protocol that is patient-centered and individualized.
Satisfaction surveying opens a dialogue with patients and lets them know providers are
listening, identifies issues with intervention, and recognizes opportunity to make improvements
and be more efficient (Coville, 2011). The Self-Care Revised-Inventory tool is specific to
diabetes mellitus (DM). Post-intervention assessments in comparison to pre-intervention
assessments will help determine if the MHA program improves self-care perception.
Researchers found that MHA’s lead to improvements in patient satisfaction, a stronger
perception of self-care practices, and satisfaction with treatment suggesting this type of
technology may be an effective strategy for changing patient self-care behaviors (Bonoto et al.,
2017).
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Protection of Human Subjects
Protection of human subjects is of high priority with any type of research or EBP project.
According to the Belmont Report of 1979, scientific research has produced social benefits as
well as some troublesome ethical practices (Beauchamp, 2008). From this report three
principals have been found to be most relevant to research involving human subjects. Those
principles include respect for the person in which that individual should be treated as an
autonomous agent and protection allotted for those with diminished autonomy (Beauchamp,
2008). A second principle is beneficence and is understood as the kindness that goes beyond
stand obligation to a person, in which the research shall maximize benefits, and do no harm to
the human subjects. The final principle is justice and is understood as a sense of distributed
fairness in which each person has an equal share according to individual need, individual effort,
each person’s societal contribution, and to each person according to merit (Beauchamp, 2008).
The DNP student for this project completed a certification program by the National Institutes of
Health (NIH) for the protection of human research participants. Additionally, a class on ethics
was completed to solidify the significance of ethical interactions with human participants.
Anonymity was maintained through use of an ordinal number coding system (See
Appendix K) as the participants consented to join the EBP project. They were instructed to keep
their number confidential and only identify themselves by that number. The participant names
and associated numbers were documented and kept confidential in a locked cabinet at the DNP
student’s office. The number identification process would also be utilized by the DNP student or
designee during check point follow-ups to maintain anonymity. Compliance tracking tools and
excel spreadsheets will only reflect the code number of each corresponding participant in the
project. Participants were given full disclosure at the initial meeting and the ability for them to
consent and emphasizing the ability to withdraw from the MHA program for any reason. This
particular project allows patients to continue with MHA usage even in the event they want to
withdraw from the project without cost or penalty. Participants that agreed to partake in the
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project did not receive any money or coercion tactics; joining was completely voluntary. An
exempt review application was pursued and approved by the Institutional Review Board at
Valparaiso University for this project.
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CHAPTER 4
FINDINGS
To determine the effects of a MHA on adults with uncontrolled T2DM in the primary care
setting statistical testing was completed to analyze the impact on HbA1C, SCP, and SCB. SPSS
22 was used to perform paired sample t tests to compare the primary outcome measure of preand post-intervention HbA1Cs. Two secondary outcome measures were also analyzed in this
EBP project. A paired sample t test was used to compare pre- and post-intervention SCP, and a
Wilcoxon Matched Pairs analysis was performed on this data to determine the effect of a MHA
on participant perception on SCB activities.
Participants
A retrospective chart audit produced 150 potential participants who met inclusion criteria
for the project. The project leader made telephone contact with 40 individuals who met inclusion
criteria. Twenty-five participants agreed to participate the Living Sweet pilot program of which 18
completed the program. The seven that did not start the program, complete the final HbA1C,
complete the final SCI-R, or satisfaction survey were excluded from statistical analysis (See
Figure 4.1). Pre- and post-intervention characteristics were identical as discussed in Chapter 3,
and the statistical analysis used was selected based on a within group design. Those who
participated in the intervention were reflective of the adult uncontrolled T2DM population within
the organization. Eighteen patients, five men and 13 women with a mean age of 52.2 years (SD
= 8.02, range 43-71), completed the Living Sweet MHA program. All participants were
Caucasian. Their mean duration with T2DM was 12.7 years (SD = 7.9, range 0.5-31) (See
Table 4.1). All of the advanced practices nurses of the organizational completed referrals to the
Living Sweet MHA program, and the physicians did not participate.

Mobile Application to Improve Glycemic Outcome

53

Figure 4.1. Participant Recruitment
Potential participants from
chart audit
N= 150

Phone contact for initial
check point meeting
N= 40

Declined
participation in
program
N = 14

Agreed to participate and
started the program
N = 25

Completed
program
N=18

Did not
complete program
N=7
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Table 4.1
Participant Demographic Data
Characteristic
N=
Age, mean, (SD), range
Sex, women/men
Years with T2DM, mean, (SD), range
Weeks of data input, mean, (SD), range

Frequencies/Results
18.0
52.1 (8.02), 43-71
13/5
12.7 (7.9), 0.5-31
6.7 (2.0), 3-8
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Changes in Primary Outcomes
The effects of a MHA on glycemic control was evaluated using the statistical test of
paired sample t test to determine the difference between the pre- and post- intervention
outcome measure of HbA1C. Paired t tests are used to make comparisons of within group
designs at two different points in time (Cronk, 2018). Pre-intervention data were collected
through a retrospective chart audit of all adults with T2DM, and those with HbA1C of greater
than 8.0 who met inclusion criteria were invited to participate. Phone contact was made to each
qualified participant to inquire about joining the EBP project, and those that agreed attended an
initial check point meeting describing the program details and responsibilities. During an 8-week
period, participants recorded SCB outcome measures daily into the MHA. This data included
glucose monitoring results, activity engagement efforts, and medication adherence efforts that
each participant completed. The project leader received the data through the export function of
the MHA. Exported data would be reviewed by the project leader, and at that time it would
determine if participants met or did not meet the goals that they had set for themselves at the
initial start-up meeting. Participants were expected to meet their self-determined goal 100% in
order for the SCB to be considered met. Nurse practitioners also received exported data from
the project leader to keep them informed of their patient progress in the program. At the 8-week
final check point meeting a post-intervention HbA1C, SCI-R and a satisfaction survey was
completed.
Glycemic Efficacy
The measures of glycemic efficacy, obtained from retrospective chart audits of preintervention HbA1C (M = 9.95, SD = 1.07) and post-intervention HbA1c results (M = 8.20, SD =
1.10) were evaluated using paired t tests. The decrease in the HbA1C was found to be
statistically and clinically significant (t = 6.674, df = 17, *p <.05). See figure 4.2
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Figure 4.2. Glycemic Efficacy
Glycated Hemoglobin
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Changes in Secondary Outcomes
Two secondary outcomes were analyzed. Evaluating the effects of the MHA on SCP and
SCBs were secondary purposes of this EBP project. Patient satisfaction was an outcome of
interest because utilizing a MHA that produced dissatisfaction would be counterproductive to the
improvement of SCP and SCB.
Self-Care Perception
A SCI-R survey was completed at the initial and final check point meeting for each
participant who completed the program (N = 18). This tool was reported within the literature as
being valid and reliable (Weinger, Welch, Butler, & La Greca, 2005). Reliability testing was
completed using Cronbach’s Alpha analysis, which found the tool reliable (.796). Validity testing
was also completed using a 1-tailed Pearson’s Correlation Coefficient. Pre-intervention SCI-R
indicated significant validity of the tool (.683, p = .001) as did post- intervention validity testing
(.683, p = .001).The survey scores were totaled and a paired t test analysis was completed on
pre-intervention scores (M = 34.6, SD = 10.5) and post-intervention scores (M = 42.6, SD =
8.09). The findings indicated that there was a statistical and clinical significance in SCP (t = 4.403, df = 17, *p < .05) (See figure 4.3) Pre- and post- intervention SCP comparisons were
also made of the behaviors that were the focus of this EBP project. This included personal
perception of checking glucose, recording glucose, activity engagement, and medication
adherence (See figures 4.4, 4.5, 4.6, 4.7).
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Figure 4.3 Total Self-Care Perception
SELF CARE PERCEPTION
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Self-Care Behaviors
Participants recorded behaviors of medication adherence, glucose monitoring, and
activity engagement according to the personal goals set by each participant. Over the course of
the 8-week program, behaviors entered into the MHA across all three domains. Frequency
analysis was completed to determine adherence to the use of the MHA, and expressed as
percentages. Across all three domains the highest frequencies were at week 1 and week 2 for
glucose monitoring ( 72.2%, 72.2%) and medication adherence (88.9% and 94.4%). Glucose
monitoring declined by week 8 (55.6%) as did medication adherence at week 8 (72.2%). Activity
engagement was highest at week 1 (72.2%), and declined significantly by week 8 (38.9%) (See
Figure 4.4). Behaviors monitored throughout the 8-week period were important to evaluate
program adherence of participants while using the MHA, but statistical analysis were not able to
be performed due to lack of pre-intervention behavior assessment for comparison. However,
pre- and post- intervention SCP comparisons were made of the behaviors that were included in
this EBP project. Behaviors included participant perception of glucose checking, recording the
glucose result into the MHA, medication adherence, and activity engagement, and results were
drawn from pre- and post- intervention SCI-R surveys (See figures 4.5, 4.6, 4.7, 4.8). A
Wilcoxon test examined the results of pre- intervention and post- intervention of checking
glucose. A significant difference was found in the results (Z = 2.389, *p < .05). Post- intervention
results were significantly better than pre- intervention results. A Wilcoxon test examined the
recording of glucose results pre- intervention and post- intervention. A significant difference was
found in the results (Z = 2.666, *p < .05). Post- intervention results were significantly better than
pre- intervention results. A Wilcoxon test examined pre- and post- intervention of participant
adherence to their prescribed medications specific to the treatment of their T2DM. A significant
difference was found in the results (Z = 2.313, *p < .05). Post- intervention results were
significantly better than pre- intervention results. A Wilcoxon test examined pre- and post-
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intervention of engagement of activity. A significant difference was not found in the results (Z =
1.718, p > .05). Post- intervention results were not better than pre- intervention results.
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Figure 4.4. MHA Recorded Self-Care Behaviors
Program Adherence
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Figure 4.5 Perception of Checking Glucose
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Figure 4.6 Perception of Recording Glucose
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Figure 4.7 Medication Adherence Perception of Medication Adherence
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Figure 4.8 Perception of Activity Engagement
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Participant Satisfaction
A Likert-scaled satisfaction survey was created that focused on the MHA used for this
project (MySugr®). Individual scores for each category on the satisfaction survey determined that
participants were satisfied with the use of the MHA (See Table 4.2). Participants rated a relatively
high score for cumulative satisfaction for the use of a MHA (M = 31.94, SD = 3.81). High score
for the survey was 35. (See Table 4.2).
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Table 4.2
Participant Satisfaction
Category

Range

Download Application
Use of Application
Exporting Data
Track Glucose
Track Activity
Track Medication
Overall Satisfaction
Cumulative Score

3, 5
4, 5
3, 5
4, 5
3, 5
4, 5
4, 5
22, 35

Mean
4.6
4.7
4.6
4.7
4.6
4.7
4.7
31.94

SD
0.70
0.49
0.70
0.49
0.70
0.49
0.49
3.81
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Conclusion
In summary, statistically and clinically significant results were found with use of a MHA
regarding the effect on HbA1C and SCP. Interestingly, there was a notable inverse relationship
between HbA1C and SCP. When SCP was at the lowest point, HbA1C was at the highest, and
when SCP was at the highest point, HbA1C was at the lowest point. There was a statistically
significant difference for participant SCB perceptions for checking glucose, recording glucose,
and medication adherence. However, activity engagement was not found to be significantly
different. Satisfaction scores were high, and according to survey results participants’ expressed
liking the application’s overall functionality and ease of use.
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CHAPTER 5
DISCUSSION
The EBP project was completed to examine the clinical research question: What is the
best practice for adult T2DM patients to achieve glycemic control and improve self-care
behaviors. Additionally, the clinical question addressed the impact of a MHA on self-care
perception. This project was posed to identify what intervention has been found, through best
evidence, to achieve glycemic control in adult T2DM patients, thereby lessening debilitating
complications related to chronically elevated HbA1C levels. High level literature supports the
use of mobile-phone technology to improve glycemic outcomes for those adults with
uncontrolled T2DM. The goal of this EBP project was to implement an intervention that utilized a
multi-functional MHA to encourage self-care behaviors of glucose monitoring, activity
engagement, and medication adherence. This chapter will explore the project findings, describe
the benefits of the selected EBP framework, strengths and weaknesses, and implications for the
future.
Explanation of Findings
The PICOT question for this project asked: “In adult T2DM patients with HbA1C values
higher than 8.0 in a primary healthcare setting (P) what is the effect of a mobile-phone diabetes
support application (I) compared to traditional diabetes education (C) on HbA1C results, selfcare behaviors, and self-care perception (O), over an 8-week period (T)?” The findings will
reflect the answers to the burning question that was the impetus for this EBP project.
Initially, a total of 40 participants were selected for this EBP project, 25 of which agreed
to participate. Of the 25 participants, 18 completed the program and eight of them did not start
or did not complete the final check point evaluation at week eight making the completion rate
72%. Completing the final check point was critical to the project evaluation because at that point
post-intervention data was collected for comparison purposes. This data collection included
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post-intervention collection of a HbA1C, SCI-R survey, assessment of behaviors recorded by
the participant, and a satisfaction survey.
Glycated Hemoglobin
After 8-weeks of the intervention, the final HbA1C, SCI-R, SCB, and satisfaction surveys
were recorded by the project leader. The primary outcome measure was to determine the
difference between pre- and post- intervention HbA1C results. A statistical analysis was
performed using a Correlated t test, and the findings resulted in a statistically and clinically
significant improvement (t = 6.674, df = 17, *p <.05) in the reduction of HbA1C. The data
revealed a mean reduction of HbA1C of the post-intervention results (M = 8.20, SD = 1.10)
compared to the pre-intervention results (M = 9.95, SD = 1.07). The mean reduction in HbA1C
was 1.75%. This finding was higher than what was found in some of the literature (Hou, Carter,
Hewitt, Francisa, and Mayor, 2016; Pal et al., 2014; Wang, Xue, Huang, Huang, and Zhang,
2017), and in some pieces of literature the findings were similar (Fu, McMahon, Gross, Adam,
and Wyman, 2017; Wu, et al., 2017. The higher reduction in HbA1C may be attributed to the
Hawthorne effect that is frequently associated with people when they know their performance is
being closely monitored (Kenton, 2019). According to the integrative review by researchers Fu,
McMahon, Gross, Adam, and Wyman (2017), HbA1C was reduced 0.15-1.9% from baseline,
and statistical significance was found in studies in which MHAs were multi-functional and
interactive. A systematic review by Wang, Xue, Huang, Huang, and Zhang (2017), found that
the use of MHA technology resulted in a decreased HbA1C of 1.0 %. Researchers of another
systematic review found that the MHA-based intervention was associated with HbA1C
reductions of 0.66% - 1.96% (Wu, et al., 2017). Pal et al. (2014) found a modest HbA1C
reduction of 0.50% with use of a MHA, and Hou, Carter, Hewitt, Francisa, and Mayor (2016)
found a mean HbA1C reduction of 0.41%.
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Self-Care Perception
Uncontrolled T2DM places the individual at risk for severe complications and complex
comorbid conditions including, heart disease, stroke, renal disease, vascular disease,
neuropathy, amputations, and death (ADA, 2018). T2DM is a chronic disease that demands
daily assessment and care by those afflicted with the disease. The daunting task of self-care
management for this chronic disease is challenging and overwhelming in many cases (Vermeire
et al., 2005). For this reason, SCP was evaluated in this EBP project to determine the impact of
the MHA. SCP is one’s belief people can care for themselves, and the use of MHAs seems to
strengthen perception of self-care by contributing better information and health education to
participants (Bonoto, et al., 2017). The higher the SCP score the better one believes they can
care for themselves. The tool used to assess SCP was the SCI-R self-report survey. This tool
was found to be reliable and valid in the literature (Weinger, Welch, Butler, & La Greca, 2005)
and through statistical testing. A Correlated t test was calculated to compare the mean preintervention SCP to the mean post- intervention for the 8-week intervention. A statistically
significant increase in SCP results were found post- intervention (M = 42.6, SD = 8.09)
compared to pre- intervention (M = 34.6, SD = 10.5) (t = -4.403, df = 17, *p < .05). For
comparison purposes, pre- and post- intervention data specific to the SCP of checking glucose,
recording glucose, activity engagement, and medication adherence were analyzed (Figures 4.5,
4.6, 4.7, 4.8). This comparison was not reported individually within the literature, however the
changes between pre- and post-intervention perceptions in these areas illustrates how SCP was
impacted through the use of a multi-functional MHA. The improvement in SCP with the use of a
MHA was similar to the results found within the literature. A systematic review found the use of
MHA seemed to improve SCP by increasing information and health education of
patients.(Bonoto, et al., 2017). Clement et al. (2018) suggested that technology such as MHAs
increased patient satisfaction and knowledge improving self-management perceptions. The
findings provide evidence that using a MHA improves SCP and suggests participants feel more
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confident when preforming self-care activities for the management of their uncontrolled T2DM.
For the purpose of this project, analysis of specific behaviors related to this project within the
SCI-R tool were completed to compare self-reported pre- and post- intervention results (see
figures 4.5, 4.6, 4.7, 4.8).
Self-Care Behaviors
SCBs for this project were glucose monitoring/recording, activity engagement, and
medication adherence. These are three of the self-care management behavior domains
recommended by the ADA that lead to the reduction of HbA1C (ADA, 2018). A frequency
analysis for each week was completed on each behavior to determine participant adherence to
the use of the MHA. Initial percentages were high with a steady decline that occurred over the
course of the 8-week period (see figure 4.4). This may be have been due to the lack of
evaluating participant recorded SCB practices prior to the initiation of the MHA. Evaluating this
prior to starting the MHA may have demonstrated a more accurate representation of
participation patterns. This should be a consideration for future EBP projects and
organizational outcome measures that focus on evaluating SCB practices related to the use of a
MHA. One week after participants used the MySugr® MHA, recorded behaviors were reviewed.
High completion percentages which were most likely due to the Hawthorn effect. This
phenomenon occurs when people feel their performance is being monitored, thus causing an
excessively high performance of activity or completion of duties (Kenton, 2019). Weeks 2-4
showed a decrease in SCB’s, between week-5 and week-6 there was a slight increase in the
percentage of successfully met behavior goals. This was most likely due to staggered start
process in which all participants completed the 8-week program but joined and finished at
different points in time. Participants who joined during the initial participants’ weeks 5 and 6
were also subject to the Hawthorn effect. During this particular timeframe, seven new
participants joined the program, and I believe this relates to the spike in SCB adherence.
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Analysis of specific behaviors related to this project within the SCI-R tool were
completed to compare self-reported pre- and post- intervention results (see figures 4.5, 4.6, 4.7,
4.8). There was a statistically significant improvement in the perception of SCBs for checking
glucose, recording glucose, and medication adherence when comparing pre- and postintervention results. There was not a statistically significant difference in perception of activity
engagement between pre- and post- intervention data. According to Bonoto et al., (2017),
participants reported that they felt like they engaged in these key behaviors and when
preformed consistently led to improvements in glycemic control and patient outcomes.
Literature supported the use of MHA’s to enhance SCB practice for adults with T2DM (Bonoto et
al., 2017; Clement et. al., 2018;; Mann, 2018; Nguyen, 2018; Pamaiahgari, 2018). Findings in in
the literature indicated that integration of a MHA for the self-management of T2DM may result in
reductions of HbA1C and glycemic and cardiovascular risk factors (Clement et. al., 2018). Selfmonitoring of glucose is a main strategy to attain glycemic control, which is a main component
of MHA’s. Thus, MHA’s encourage SCBs that result in reductions in HbA1C which emphasizes
the importance of using this technology in the primary healthcare setting (Bonoto et al., 2017).
The literature used in this project identified 11 different MHAs that were used by the intervention
groups. Application features included health data storage, positive feedback parameters, and
motivational feedback for glucose, activity, and medication recording, all of which were present
in the MySugr® MHA. All of these features were found to contribute to glycemic control (Fu,
McMahon, Gross, Adam, & Wyman, 2017; Hou, Carter, Hewitt, Francisa, & Mayor, 2016; Wu et
al., 2017; ). Subgroup analysis determined that MHAs with features such as positive feedback
and glucose, activity, and medication recording generated better and statistically significant
improvements in HbA1C (Bonoto et al., 2017). A clinical practice guideline (Clement et al.,
2018) did not report individual SCBs as an outcome, but noted that the MHAs with the features
mentioned above improved SCB adherence, improved access to health care professionals, and
contributed to better glycemic control. A systematic review indicated that MHA engagement
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decreased over time, however statistically significant reductions in HbA1C were achieved
(Bonoto et al., 2017). It was noted that reductions in HbA1C may have been due to factors
unrelated to the MHA, such as increased knowledge regarding the implementation of the MHA
platform to record and encourage behaviors related to reducing HbA1C. This reinforced
knowledge about behavior changes that lead to improved HbA1C, which may have caused
improvements in self-care changes leading to improved HbA1C. Interestingly these researchers
found generally high participant engagement for all components of the MHA the first week and
then decreased engagement progressively overtime consistent with the behavior pattern
observed in this EBP project. Additionally, they found that blood glucose monitoring had a
statistically significant improvement while activity engagement did not (Bonoto et al., 2017).
These findings were similar to the findings of this EBP project, (Bonoto et al., 2017). Best
practice recommendations include MHA-based support programs for the management of
diabetic patients (Pamaiahgari, 2018), and structured self-monitoring of blood glucose was
found to be more beneficial than non-structured self-monitoring of blood glucose testing in
reducing HbA1C (Nguyen, 2018). Structured self-monitoring means that glucose checks are not
only encouraged but a technologically platform is provided to record, store, and export selfmonitored blood sugars. A systematic review by Hou, Carter, Hewitt, Francisa, and Mayor
(2016) promoted MHAs to improve patient self-management with the enhanced ability to
monitor blood glucose, physical activity, and medication adherence.
Participant Satisfaction
Participant satisfaction was also evaluated because this is an important aspect when
selecting a MHA as patients desire one that is considered easy to use and understand (Fu,
McMahon, Gross, Adam, & Wyman, 2017). Researchers suggest that MHAs that are user
friendly and multi-functional are best for improving SCB’s that lead to improved glycemic control
(Fu, McMahon, Gross, Adam, & Wyman, (2017).
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Cumulative patient satisfaction results for the use of a MHA in this project reflect high
satisfaction (M = 31.94, SD = 3.81) with a range of 22,35. Individual satisfaction domains
specific to the focus of this EBP project included tracking glucose, activity, and medication
adherence and recording. Interestingly, tracking glucose and inputting data onto the MHA were
ranked the top two domains in satisfaction. This may be due to the user-friendly aspects of the
device, and to the positive reinforcement in real-time elicited by the application when data was
entered. MySugr® has a “sugar monster” on the application and he smiles and giggles or frowns
and scowls accordingly to normal or abnormal blood sugars. The “sugar monster” also turns
colors based on the blood sugar number entered with green signifying a normal range, yellow
approaching out of range, and red representing a result that was out of range. This was a
unique positive reinforcement system and immediate feedback system specific to this MHA.
Tracking activity and medications had lower satisfaction ratings, but only by a slim margin. The
“sugar monster” would consistently be green, smile and giggle anytime activity and medications
were entered into the MHA. Again, this provided consistent positive reinforcement in real-time.
Literature suggests that MHA use increased patient satisfaction of self-care management
behaviors by enhancing knowledge and promoting improvement in quality of life and selfconfidence to manage T2DM (Bonoto et al., 2017; Clement et al., 2018). The heightened SCB
practices, self-confidence, and self-care knowledge fosters improvements in HbA1C and
decreased risk of complex comorbid complications.
Strengths and Limitations of the DNP Project
EBP Model
The EBP framework used to guide this EBP project was the Iowa model of evidencebased practice to promote quality care. The Iowa model provided a conceptual framework for
the selection and development of this EBP project. It consists of seven steps: selection of a
topic, forming a team, evidence retrieval, grading the evidence, developing an EBP standard,
implementing the EBP standard, and evaluation (Titler et al., 2001). Step I was the selection of
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a topic which included the task of identifying an organizational quality measure that was falling
below metric standards set forth by key reimbursement agencies such as CMS. Included in this
selection process was the consideration of current policy, organizational mission, and key
stakeholder influence that may produce limitations for the project. It was found that in quarterone of 2019 that 59.3% of diabetics within the primary care organization had HbA1C results of
greater than 9.0, while quarter-two indicated that 66% had HbA1C greater than 9.0. These are
considered poor quality measure outcomes and are well above the expected national standard
of 45% or less of adults with diabetes mellitus having a HbA1C of less than 9.0 (CMS, 2017).
Uncontrolled diabetes mellitus is directly linked to complex conditions and complications that
include: Cardiovascular disease, stroke, diabetic ketoacidosis, kidney disease. eye disease, and
amputation of a lower extremity (CDC, 2017).The use of a MHA to encourage adults with
uncontrolled T2DM to improve completion of self-care behaviors ultimately leading to improved
HbA1C results. Reducing HbA1C was a priority for the stakeholders of this organization, i.e.,
physicians, nurse practitioners, quality management, risk management, and senior leadership.
The idea of using a MHA in the primary care setting did not take hold as the project leader
expected it would. Several meetings and presentations occurred with individuals and groups of
stakeholders to promote the EBP project. Support for the project development was mainly
provided from quality and risk management leaders, while nurse practitioners heavily supported
the implementation process. Physicians did not want to engage in any of the development,
implementation or evaluation phases due to the time involved. One physician voiced opposition
of adding a MHA as a primary care provider-driven tool, due to time constraints and how this
may negatively impact quarterly revenue bonuses. The original protocol was primary care
provider-driven, but senior leadership thought it would be better utilized as a nursing
intervention standard in the diabetes education program that was needing serious revisions. It is
now recognized that the diabetes outcome metric is not being met within the organization, and
loss of reimbursement by CMS is at risk. The Chief Nursing Officer (CNO) recommended use of
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the MHA as an evidence-based tool for the management of adults with uncontrolled T2DM, and
to improve outcomes for the organization. The project is now being integrated into the diabetic
chronic care management and transitional care management programs of the organization. The
protocol will need to be reviewed by medical staff for approval and modifications will occur as
recommended. Modifications may include setting different target ranges for blood glucose
results and blood glucose monitoring intervals for those on insulin and those who do not use
insulin. These target ranges would need to be determined by the patient care review committee
as a guide to the diabetes care team.
Step II is the engagement of a team that will be responsible for the development,
implementation, and evaluation of the project. The makeup of the team is driven by the chosen
topic and include associated stakeholders (Titler, 2001). The project leader determined that a
small interdisciplinary team would be best for the development of this EBP project. The
organization is considerably small and generally functions on a more intimate level of
communication. The team included the project leader, project preceptor/quality manager, and
the risk manager. It was impressive to see the level of attention that was given to the project by
the project preceptor/quality manager and the risk manager. The project preceptor/quality
manager was involved in the development and workflow of initiating the MHA. She came to the
office of the project leader on a few occasions to discuss the literature findings, protocol
development, and recruitment efforts. Additionally, she integrated the program into the EMR to
streamline the referral process for the nurse practitioners. The risk manager reviewed the IRB
from Valparaiso University, all of the forms that were created for the project, and the focus of the
project. The project leader was impressed with the enthusiasm of these team members and
appreciated the recommendations from these leaders. The nurse practitioners were considered
the key stakeholders due to the probability that the majority of the referrals would be coming
from them. Two of the nurse practitioners who originally said they would start participants on the
program did not do so. The project leader ended up meeting with all 26 of the potential
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candidates and then followed the 18 participants for 8 weeks without participation of the other
two nurse practitioners. Their assistance may have increased the number of participants that
joined the program. The physicians showed extreme resistance to the project, and the project
leader’s collaborating physician stated he did not want to take the time to start a patient on the
MHA. He indicated from the start that the MHA may have a place in the organization, but should
not be physician or nurse practitioner driven. The project leaders does not agree with this and
believes the use of the MHA to reduce HbA1C should remain a primary care provider-driven
practice guideline as nurses cannot make medication adjustments that are often needed to
improve glycemic control. Activity adjustments and glucose monitoring would also need to come
from the primary care providers. Advanced practice nurses are well suited to make these
adjustments based on exported data and improve outcome measures while reducing risk of
secondary complications. The project leader did not receive any referrals from a physician.
However, the project leader was able to speak to some of the physicians’ patients, and they
agreed to join the program. The physicians did not resist their patients being in the program and
accepted the exported data by email from the project leader without issues. When a participant
joined the program, their provider was made aware of their patient’s informed decision and
instructed to expected exported data in their email weekly. This information kept them prepared
and helped them understand what to expect from the project leader.
Step III entails evidence retrieval. Brainstorming amongst the members should be held
to identify available resources to guide the search for evidence (Titler et al., 2001). Once the
priority was established, the quality and risk leader team members assisted in the development
of the EBP project. The project leader retrieved and evaluated the level and quality of the
evidence and explained it to the quality and risk team members. This was a lengthy and
exhausting process, but necessary to assist the other team members’ full understanding of what
EBP entails. Much of the discussion focused on the project implementation process and
retrospective chart review. The quality leader was able to pull the names of the patients with
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T2DM that had HbA1C greater than 8.0, which was essential to evaluate the full scope of the
problem within the organization. The risk leader was essential in making sure the written forms
for the project were clear and did not put the hospital at risk or litigation. The project leader’s
main role was to ensure the evidence was at the highest level and quality available and to keep
the other team members informed of the findings.
Step IV is the process of gathering, critiquing and synthesizing pertinent research related
to the desired practice change (Titler et al., 2001). In this case, the project leader was required
to appraise the strength and quality of the evidence that was found as a result of an exhaustive
literature search. Through this search it was determined that there was an large amount of high
evidence available to support change in practice. Evidence was leveled through Melnyk and
Fineout-Overholt’s Hierarchy of Evidence ( Melnyk & Fineout-Overholt, 2015). Critical appraisal
of the evidence was completed through use of the CASP tool (CASP, 2017), and the AGREE II
tool for clinical practice guidelines (Brouwers et al., 2010).
STEP V is the development of a new practice based on a patient-centered evidencebased practice standard that is highly individualized. Once the literature is critiqued, team
members develop a set of recommendations that guide the new practice (Titler et al., 2001).
The project leader created an individualized patient-centered EBP protocol/ practice standard
for the organization that was revised continually throughout the implementation process as
barriers were encountered. The first barrier was experienced as the new practice standard was
introduced to the organization came with a significant barrier. The Living Sweet MHA program
was recommended to be initiated as a nursing intervention, but because nurses cannot adjust
medications, glucose testing intervals, or activity recommendations at this organization, the
primary care providers had to manage these aspects of the program. This meant the practice
change would need to go through the patient care review committee before it could be added to
the approved diabetes education regimen. The patient care review committee is comprised of
only physicians. This barrier will be addressed through a presentation at a future patient care
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review committee meeting. Additionally, selecting a MHA for this project also became a
challenge due to the abundant options to choose from. The project leader sampled and
reviewed roughly ten applications before selecting MySugr®. This particular MHA was free to
use, was multi-functional and included the ability to document all three behaviors being
monitored in the EBP project, was very user-friendly, came with a color-coding system to help
the user determine if the blood sugar was in good range (green), moderate range (yellow), or
poor range (red).
The start-up meeting consisted of a complete in depth instructional in-service for each
participant with emphasis on the use of the MHA, selecting personal goals for each behavior,
and specific project leader and participant responsibilities. Weekly check points were used as a
teaching moments to reinforce the proper use of the MHA, self- selected behavior goals, and to
clarify any concern or question a participant had regarding the MHA. The new practice standard
protocol was reviewed after implementation by all team members, and it was suggested that it is
more relevant and feasible as a nursing intervention for the diabetes education program rather
than a provider-driven practice protocol. This means that when a primary care provider sends a
referral to the diabetic education team, they will utilize the MHA protocol as an additional tool to
promote glycemic efficacy. The reason behind the creation of the EBP protocol is to improve the
quality and consistency of diabetic education throughout the organization. This was suggested
by senior leadership and eliminated a significant barrier that was resistance from medical staff
members. The protocol will still need to be approved by medical staff, which is made up of
physicians, but will likely be accepted as an evidenced-based tool for improved diabetic care
glycemic outcomes. The primary care providers’, including nurse practitioners’, role will be to
medically manage medication types and dosages, activity engagement, and glucose monitoring
intervals based on the exported data they receive from the patients that are using the MHA.
Once the medical staffs approves the integration of the MHA into the diabetes education
program, the nurses will start participants on the program and track their progress. Diabetes
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nursing staff will forward export data to primary care providers when exported data results are
consistently falling out of target ranges. The significance of this is the sooner the nurse
practitioner makes adjustments, the sooner the patient will reach glycemic control.
Step VI is the implementation of the new EBP standard which begins with written
policies, procedures, and guidelines. Policy development requires direct interaction between the
team members, direct care providers, and organizational leaders to support the practice change
(Titler et al., 2001). The protocol was developed and implemented with continual revisions to
meet limitations and barriers that were encountered throughout the launch of the Living Sweet
program. Revisions included adding a prompt within the protocol for the designated staff
implementing the MHA to contact the patient before the initial meeting to request their phones
are updated with the most current operating system. Another revision added was a prompt to
request patients know the email and password that corresponds to the application store on their
smart phone. Also, the protocol was changed from a provider-driven tool to a nursing
intervention for the improvement of diabetes outcome measures.
Step VII is the evaluation step which is essential to seeing the value and contribution of
applying the evidence to practice. Baseline comparison data prior to project implementation is
beneficial to show how the new evidence-based practice has affected patient care (Titler, 2001).
Data collection flowsheets were created to track the data for all outcome measures and group
demographic characteristics. The project leader completed eight check-points for each
participant (N = 18), and was available by phone for consultation regarding any concern or any
trouble shooting issues related to the use of the MySugr® MHA. The time involved in preforming
check-points depended specifically on the needs of the participants and how well they
comprehended the MHA functions. Additional time was spend reinforcing the three SCBs that
were being monitored and the steps for exportation of the data to the project leader. Initial check
points lasted between 30-45 minutes and as the program progress the check points occurred
over 10-20 minutes. Check points were integrated into the program to determine and address
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barriers and limitations. This was helpful in revising the protocol to make it more streamlined
and functional for those that were going to be providing education about the program to future
patients. This approach was not intended to be sustainable long term as once participant and
workflow issues were identified and resolved, the checkpoints would no longer be needed. In
future practice, primary care providers could set exportation expectations for each patient that
utilizes the MHA program. The project leader evaluated the outcome measure data using
statistical tests with SPSS 22 software.
Strengths
There were many strengths of this EBP project. The most profound strength was the
collaborative efforts between advanced practice nurses, senior leadership, and quality and risk
management departments. The support by key stakeholders had significant influence in the
development, implementation, and evaluation processes of this EBP project. For instance, the
quality leader volunteered an abundant amount of time to help determined the number of that
adults with uncontrolled T2DM that were well above the HbA1C benchmark according to CMS
guidelines. She also recommended that the best way to elicit provider referrals was through the
established EMR. Making the referral process streamline and simple was clearly an attraction to
the primary care nurse practitioners. Implementation was supported by risk leadership as she
critiqued the data tracking forms, instructional forms, and educational forms to keep structure
and consistency to the entire implementation process. The project leader was the member who
created the forms, contacted patients, implemented the program, and evaluated the outcome
measures of the EBP project. The literature used for this project added clarity and confidence
which was found to be a significant strong point when grooming key stakeholders and clinical
staff. For example, the high level and quality of literature found was explained and reviewed with
the primary care providers at four different meetings. These meetings were geared to sparking
interest, garnering support, and eliciting qualified participant referrals. The MySugr® basic
application was free to use for all participants which is a huge strength in the rural health care
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setting, not to mention the multi-function capabilities of the MHA to be used as an individualized
patient-centered intervention. In the event MySugr® would become cost prohibitive, there are
other free multi-functional applications with similar features and are user-friendly such as
Glucose Buddy (Glucose Buddy, 2017).
The MySugr® application allowed for simplistic data entry by simply tapping on the my
sugar icon. The user was able to enter blood sugars manually or through blue tooth technology
if their monitor was compatible. After the number was entered or uploaded from the glucometer
the user would tap the green check mark to record the data. The name of each diabetes
medication was pre-selected for each participant and by simply tapping on the medication and
then the green check mark, the data were recorded. Activities were recorded in a similar
fashion. The MHA had other functions available, but for the purpose of this project these three
SCBs were the only ones utilized. The MHA estimated the HbA1C for each participant if they
submitted six glucose results for the week. This feature was helpful as the number may have
encouraged participants to improve food selections, increase activity, or adhere to medications
based on the results produced from current blood glucose results entered. An additional
strength of the application is the participant was able to review seven days, 14 days, 30 days,
and 90 days of data, and this included cumulative blood glucoses, physical activity engagement,
and medication adherence at each data point. Furthermore, the MHA has no geographical
barriers and promoted access to the healthcare provider through the exportation function. The
opportunity to export real-time data was a significant advantage for those participants who did
not have transportation to attend a traditional office visit.
Limitations
The primary limitation was the small number of participants for the project (N = 18).
Additionally, the project was short in duration and a longer time many have resulted in different
outcomes for the primary and secondary objectives for this EBP project. Another limitation was
that many of the participants engaged in the project over two major holidays in which there is an
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abundant supply of nutritionally poor foods. People tend to increase consumption of sweets, eat
larger portions of food, and increase alcohol consumption over holidays, all of which can
increase blood glucose and HbA1C. Regardless of the limitations faced in this EBP project,
participants experienced a statistically and clinically significant decrease in HbA1C, improved
SCP and SCB. The project lacked objective pre- intervention data regarding the SCB’s included
in this project. A better approach may have been to collect SCBs from each participant prior to
initiating the MHA, and compare them to post intervention SCBs that were recorded into the
MHA. This would have reflected a more accurate representation of how SCBs were impacted by
the use of the MHA. Finally, prospective participants that did not have a cell phone or tablet
were unfortunately not able to participate in the project and were not able to benefit from the
Living Sweet program. This specific limitation only was applicable to five of the participants that
were originally contacted.
A participant related limitation was encountered early in the program. Internet connection
was found to significantly impact the time involve when uploading the MHA to the smartphone
and when inputting data. This did not cause a deterrent for the participants, but caused a barrier
for the project leader. The first participant for this EBP project was started in the program in his
home setting and it was extremely difficult to get the MHA downloaded onto his smartphone due
to poor satellite connection and download speeds. The future recommendation is that
participants start the program in the office setting with sound, consistent internet connections.
The office setting in this organization has a broadband fast internet and uploading of the MHA
took minutes versus hours with satellite internet services. Participants also seemed to have a
difficult time remembering the email and password associated with uploading applications to
their phones or tablets. The initial meeting with the first participant this was a significant issue.
This limitation was addressed early during the initial phone call by the project leader by
requesting that each participant have their email and password ready for the initial program
start-up meeting. SCBs and SCPs were self-reported, which can be a limitation because self-
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reporting is subjective and may not have been accurately reported by the participants. Despite
limitations related to self-reporting, SCBs, with the exception of activity engagement, and SCPs
showed statistically significant improvements.
Implications for the Future
Practice
Improving HbA1C using a multi-functional diabetes specific MHA could be helpful in
achieving glycemic efficacy, self-care perception, and self-care behaviors. The EBP project had
a short duration of 8-weeks, but the MHA strategy demonstrated a statistically and clinically
significant reduction in HbA1C and improvements in SCP and SCBs, with the exception of
activity engagement. Regarding adherence to the use of the MHA, post- intervention recorded
SCB activities declined over an 8-week period. Due to the suspected Hawthorne effect that
frequently occurs during monitored projects, recorded activities may have been skewed during
the initial weeks participants were using the MHA. Evaluating SCBs prior to the implementation
of the MHA would have made a better reflection of the impact that the application had on
recorded post- implementation SCBs. This was a flaw in the design of the project. Participants
recording SCB practice data prior to the use of the MHA would have been a better comparison
and provided more insight of how the application impacted SCBs. It is possible that even the
lowest percentages of the post-intervention recorded SCBs could have been higher than preintervention recorded percentages. This would have resulted in an increase in recorded SCB
activities rather than the resulting decline that was found. Within the SCI-R tool, SCBs specific
to this project were self-reported pre- and post- intervention by each participant, and those
results were individually analyzed. Findings indicated that SCBs of checking glucose, recording
glucose, and medication adherence demonstrated statistically significant outcomes. Activity
engagement was not found to be statistically significant.
Participants reported high satisfaction regarding the use of the MHA which is a bonus
attribute that may lead to better adherence to a program geared at improving HbA1C. This EBP
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project mean HbA1C result surpassed the primary outcome benchmark set by CMS of 9.0. This
is clinically and statistically significant and suggests that providers should consider using the
MHA to improve glycemic control in adults with uncontrolled T2DM in a primary care setting.
Due to the lack of medical staff support it was suggested by senior leadership to transition the
protocol into a nursing intervention. This was a significant suggestion, and the protocol was
adopted by the organization as an additional tool to support adults with uncontrolled T2DM. At
this time, the basic functions of the MySugr® MHA is free to anyone who would like to use it.
Basic functions included recording of glucose, activity, medications, carbohydrates, weight, and
HbA1C results. The Iowa model used as a guide for the creation of this EBP project supports
the team collaboration concept. This was clearly demonstrated by the collaborative healthcare
team involved in the development, implementation, evaluation, and dissemination of the project.
The importance of a team approach when establishing EBP protocol is due to the need for
interdisciplinary engagement the new practice standard brings to the organization and brings
other disciplines into the rollout process of the new practice standard. An example is the
process of training the nurse-driven diabetes education team about the Living Sweet program. It
is essential for these nurses to be well versed on how to download, use, and export data for the
MySugr® application to an Android® or an iPhone® efficiently and effectively. Additionally, they
will need to know how to change medication profiles and target blood sugar ranges as
requested by primary care physicians, nurse practitioners, and physician assistants. The
information technology leader was also brought into the project design portion. During the pilot
the project leader received all of the EMR referrals, and this needed to know be delegated to the
diabetic education team. Including the information technology leader in this project was
essential to streamline the referral process to the appropriate people. The Iowa model has
distinct team building attributes and that is why it was selected for this EBP project.
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Theory
This project was guided by the Iowa model of evidence-based practice to promote
quality care because of the team approach that is encouraged by the model to promote
organizational change. The Iowa model guided the integration of the weekly check-point
evaluations which encouraged continual revisions of the project until an efficient sustainable
protocol was reached. Much like the Iowa model’s internal check and balance system, these
check points were an internal evaluation of the project as it progressed. The model added clarity
to the process and encouraged project leaders to assess and address barriers and limitations
throughout the evaluation process.
Research
Further research and education are needed to determine if reduction of HbA1C, SCP,
and SCB improvements are sustainable using a diabetes-specific multi-functional MHA. The
exportation of participant data to providers was instrumental to encourage accountability and
positive impact on HbA1C, SCP, and SCB. An extended timeframe would be especially helpful
in determining the impact on primary and secondary outcomes as well as participant
engagement and attrition. Including a larger number of participants of different races, socioeconomic status, and different healthcare settings would help determine generalizability and
feasibility. Recorded SCBs showed a decline over the 8-week implementation, however this was
not a true reflection of adherence to the use of the MHA because pre-intervention SCB analysis
was not completed in this project. Evaluating pre- intervention recorded SCBs and comparing
them to post- intervention recorded SCBs would have added more value and clarity to this data.
Perceived SCBs showed an increase in over the 8-week implementation period, with the
exception of activity engagement, which did not show improvement after the MHA was
implemented. Also, an extended follow-up evaluation of six to 12 months of the HbA1C results,
SCPs, and SCBs by the project leader may add merit and speak to sustainability of the use of a
MHA for the self-management of adults with uncontrolled T2DM.
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Education
Participant education was provided throughout this EBP project. The initial start-up
meeting included printed material, and from that material dialogue was initiated by the project
leader. Additionally, printed material was also created to guide the providers about the details
and goals of the Living Sweet MHA program. This was designed to help them introduce the
program to potential participants. The printed material included explanation of the referral
process that was embedded in the electronic medical records. The material also informed
providers that they would be receiving exported weekly data from their patients who decided to
join the program. Prior to this EBP project the project leader and the other providers at the
organization had not used smartphone applications to promote glycemic efficacy, SCPs, or
SCBs. The nurse practitioners were key for educating their patients about the program and for
initiating referrals through the electronic medical record and secured email system. They
provided the project leader with warm referrals to the Living Sweet program and this allowed for
a successful pilot.
Primary care physicians, nurse practitioners, and physician assistants have the
responsibility to stay educated on technologic advancements that may empower individuals to
not only manage their chronic disease, but to make improvements on outcome measures and
prevent complex comorbid conditions. It is imperative they attend continuing education
conferences and stay engaged in high level and high-quality literature.

Conclusion
The findings of the EBP project determined that the diabetes-specific multi-functional
MHA contributed to improving HbA1C, SCP, and SCB with the exception of activity engagement
in the primary care setting. Moreover, use of a MHA for adults with uncontrolled T2DM is a
feasible, sustainable, evidence-driven intervention that can contribute to diabetes self-care
practices and prevention of comorbid conditions related to uncontrolled T2DM. This EBP project
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used MySugr® smartphone application, but use of other MHAs are expected to reach similar
outcomes to those found in this project. Other applications that are free of charge and multifunctional similar to MySugr® are Glucose Buddy®, Diabetes Pal®, and Diabetes: M®.
Findings from the EBP project were congruent with those reported in the literature and
answered the PICOT question : “In adult T2DM patients with HbA1C values higher than 8.0 in a
primary healthcare setting (P) what is the effect of a mobile-phone diabetes support application
(I) compared to traditional diabetes education (C) on HbA1C results, self-management
behaviors, and self-care perception (O), over an 8-week period (T)? It was determined that the
use of a MHA should be encouraged by primary care providers to promote glycemic efficacy,
improve self-care perception, and promote self- care behaviors, such as glucose monitoring and
recording and medication adherence, ultimately leading to a reduction in complex comorbid
conditions. Nurse practitioners will monitor data exported by patients using the information to
change medication regimens and dosages, activity recommendations, and glucose monitoring
intervals to promote glycemic control and improve SCP and SCB practices.
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Appendix A
Clinical Protocol for the Living Sweet Program

Living Sweet:
An Adult Type 2 DM
Management Program
Patients must know their email and password that is
associated with the app. store on their phones. Ensure phone
updates are completed prior to initial visit. Ensure email and
password is known for app. verification purposes.
PURPOSE: The is an evidence based project aimed at reducing
glycated hemoglobin, while fostering self-care perception and self-care
behaviors such as medication adherence, blood glucose monitoring,
and physical activity engagement through the use of a diabetes-specific
mobile smart phone application.
INCLUSION CRITERIA: Participants must be 18 years or older, have
type II diabetes, have the most recent HbA1C of greater than 8.0, and
have access to a mobile smart phone. Pregnant women are not eligible
to be in this program.

Chantel Anderson
MSN, FNP-BC
Program Leader

canderson@pmhnet.com
219-863-9298
-Melissa Jones
Pulaski Memorial
Hospital
Clinical Site Preceptor
-Dr. Christine Kurtz
Valparaiso University
Project Advisor
-Dr. Nola Schmidt
Valparaiso University
Project Advisor

•

A referral is to be made through the secure electronic medical
record to the designated program staff member.

•

The designated program staff member will confirm inclusion
criteria, discuss participant guidelines, and provide hands-on and
written instructions.

•

The designated program staff member and participant will
determine personalized goals for blood glucose testing, physical
activity, and medication administration (other self-care activities
may be added upon request).

•

Participants will utilize the diabetes-specific mobile smart phone
application to upload blood sugars, physical activity events, and
medication administration events that are patient-driven and
individualized.

•

Participants will send their uploaded results to the designated
program staff member based on a pre-determined time not to
exceed 2 weeks.

•

The designated program staff member will place reminder calls or
texts in the event results are not received at the timeframe that
was decided upon at initiation of the program.

•

Designated program staff member will review and communicate
exported data to respective primary care providers. Providers will
order specific medication regimens, activity goals, and glucose
testing intervals. This will then be communicated to the patients by
the designated staff member.
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Appendix B
Demographic Collection Form

CODE

PRE- AGE
HbA1C

DOB

SEX
1=
FEMALE
2=
MALE

001
10.0
52
7/10/67
2
002
11.0
47
2/20/72
1
003
9.7
58
4/7/61
1
004
11.5
65
2/10/54
1
005
8.9
57 12/14/61
1
006
10.9
51 12/27/67
1
007
9.2
54
7/24/65
2
008*
0
0
0
0
009
9.4
45
6/2/45
1
110
10.0
43
7/14/76
1
120
8.9
47
1/27/72
1
130**
10.6
49
5/21/70
1
140**
8.4
36
1/2/83
2
150**
12.4
42
8/5/76
2
160*
0
0
0
0
170
8.9
45
2/25/74
2
180**
11.0
45 12/14/73
1
190*
0
0
0
0
200
9.9
62
7/27/57
1
210
9.6
43
5/30/76
1
220
11.8
55
3/24/64
2
230
9.8
44
1/27/75
1
240
8.4
48
11/9/71
1
250
10.3
71
9/1/48
1
260
9.0
52
6/25/67
2
* Participant did not start the program as intended
** Participants did not finish the program

RACE
1=
WHITE
2=
BLACK
3=
HISPANIC
4=
OTHER

1
1
1
1
1
1
1
0
1
1
1
1
1
1
0
1
1
0
1
1
1
1
1
1
1

MEDICATION
1= ORALS
2= INSULIN
3= ORALS AND
INSULIN
4= ORALS AND
NON-INSULIN
INJECTIBLE
5= NONINSULIN
INJECTIBLE
6= ORALS,
INSULIN, AND
NON-INSULIN
INJECTIBLE
2
3
1
1
6
1
1
0
2
3
3
1
2
1
0
1
2
0
4
2
2
3
1
3
3

YEARS
DX
WITH
T2DM

POSTHbA1C

3
10
15
15
15
0.5
15
0
15
15
22
11
10
7
0
10
8
0
18
3
21
10
0.5
31
10

8.9
9.0
7.4
7.5
7.5
8.7
7.7
0
6.7
8.3
6.7
0
0
0
0
7.2
0
0
8.9
9.7
10.4
8.1
6.8
8.5
9.7
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Appendix C
Participant Information Sheets

Living Sweet:
An Adult Type 2 Diabetes
Mellitus Management
Program

Type 2 diabetes mellitus is one of the most chronic diseases, and the number of
people who have it is getting higher.
Staying on a treatment plan for diabetes is very hard, even when you know the
bad health events that are because of high blood sugars and glycated
hemoglobin (HbA1C).
A HbA1C above 8.0 is diabetes that is not under control. This causes diabetic
problems such as heart attacks, strokes, bad sight, loss of limbs, pain to nerves
in the feet, and bad kidneys.

Chantel Anderson
MSN, FNP-BC
Program Leader

219-863-9298

canderson@pmhnet.com
-Melissa Jones
Pulaski Memorial
Hospital
Clinical Site Preceptor
-Dr. Christine Kurtz
Valparaiso University
Project Advisor
-Dr. Nola Schmidt
Valparaiso University
Project Advisor

The use of a mobile smart phone application (APP) has shown to lower blood
sugars, increase workouts, help with medication plans, and lower HbA1C.
Living Sweet is a program at Pulaski Memorial Hospital Clinics and was made
because of research results that showed that APPs lower HbA1Cs and help to
take medication, blood sugars, and doing workouts.
When you join the 8-week program you will get hands-on and written details
for downloading the free application to your smart phone, using the APP,
setting reminders that are just about you and your goals, and uploading your
information for your health care provider to review at a time that is easy for
you. The project leader will come to you for this training.
In general, the program will use an APP that is user-friendly, time-friendly, and
can be used with an Android or iPhone. There is no cost to me.
Please ask your provider if they think you could be in this program. You must
be 18 years or older, have type 2 diabetes, have a HbA1C of more than 8.0, and
have a smart phone. Pregnant women are not able to be in this program.
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I agree to join the 8-week Living Sweet Program, and I know that I can leave at
any time for any reason without a problem.
I know that this program will not change regular health care services that I
receive from my current provider.
I know that I can join for free, and it will stay free even if I stop the program
before the end of the 8-weeks.
I know that my info will remain private and the HIPPA rules will be used with
all services that I get. My name will always be kept secret by using a

number code for the information about to me.
I agree to let the project leader get the diabetic APP data that I offer or upload
during the 8-week program.

I understand that this program is meant to help change the way I
take care of my daily diabetes by blood sugar checking, taking
medication, and physical workouts.
I understand using this phone APP is to lower a high HbA1C
results.
I understand that the data gathered from this program will be
talked about at Valparaiso University and possibly other places.
This is important to help other people care for their diabetes.
I will keep in touch with the project leader during the 8-week
program, and when I have questions about the APP or about the
program.
I agree to work with the project leader to select personal goals I
want to reach by using the APP. These goals will be about taking
medication, working out, and blood sugar testing that will help
lower HbA1C levels.

** KEEP FILLING OUT THE REST OF THE FORM 2
PAGES**
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NAME:
__________________________________________________

DATE OF BIRTH: _________________AGE:
_________________
SEX: __________________________________________________________

EMAIL:____________________________________________________

PROVIDER EMAIL:____________________________________________

RACE: _______________________________________________________

HOW MANY YEARS HAVE YOU KNOWN YOU HAD DIABETES?
_______________________________________________________________

HOW OFTEN DO YOU EXERCISE? _____________________________

MEDICATIONS:
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Appendix D
Self-Care Inventory-Revised
Self-Care Inventory-Revised Version (SCI-R) This survey measures what you actually do , not what you
are advised to do. How have you followed your diabetes treatment plan in the past 1-2 months?
1 Check blood
glucose with
monitor
2 Record blood
glucose results
3 If type 1:
check ketones
when glucose
level is high
4 Take the
correct dose of
diabetes pills
or insulin
5 Take
diabetes pills
or insulin at
the right time
6 Eat the
correct food
portions
7 Eat
meal/snacks on
time
8 Keep food
records
9 Read food
labels
10 Treat low
blood glucose
with just the
recommended
amount of
carbohydrate
11 Carry quick
acting sugar to
treat low blood
glucose
12 Come in for
clinic
appointments
13 Wear a
Medic Alert ID
14 Exercise
15 If on
insulin: Adjust
insulin dosage
based on
glucose values,
food, and
exercise

NEVER

RARELY

SOMETIMES

USUALLY

ALWAYS

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Have Type 2
diabetes

1

2

3

4

5

Not taking
diabetes pills
or insulin

1

2

3

4

5

Not taking
diabetes pills
or insulin

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1
1

2
2

3
3

4
4

5
5

@Copyright: Annette M. La Greca, University of Miami

Never had low
blood glucose

Not on insulin
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Appendix E
Check Point Tracking Form
PC/
DOB
001

WK
2
9/21

WK
3
9/28

WK
4
10/5

WK 5

WK 6

WK 7

11/2

WK
1
9/14

10/12

10/19

10/26

WK
8
11/2

10.0

9/6

002

11.0

9/12

11/8

9/20

9/27

10/5

10/12

10/19

10/26

11/1

11/8

003

9.7

10/6

12/2

10/14

10/21

10/28

11/4

11/11

11/18

11/25

12/2

004

11.5

9/26

11/22

10/4

10/11

10/18

10/25

11/1

11/8

11/15

11/22

005

8.9

9/28

11/24

10/6

10/13

10/20

10/27

11/3

11/10

11/17

11/24

006

12.3/

9/13

11/9

9/21

9/28

10/6

10/13

10/20

10/27

11/2

11/9

007

8.9/

9/17

11/13

9/25

10/3

10/10

10/17

10/24

10/31

11/6

11/13

008

x

x

x

x

x

x

x

x

x

x

x

009

9.4

9/26

11/22

10/4

10/11

10/18

10/25

11/1

11/8

11/15

11/22

110

10.0

9/27

11/23

10/5

10/12

10/19

10/26

11/2

11/9

11/16

11/23

120

8.9

10/1

11/24

10/9

10/16

10/23

10/30

11/6

11/13

11/20

11/27

130

10.6

10/8

12/4

140

8,4

10/16

12/12

150

12.4

10/1

11/27

160

x

x

x

10/16
x
10/24
x
10/9
x
x

10/23
x
10/31
x
10/16
x
x

10/30
x
11/7
x
10/23
x
x

11/6
x
11/14
x
10/30
x
x

11/13
x
11/21
x
11/6
x
x

11/20
x
11/28
x
11/13
x
x

11/27
x
12/5
x
11/20
x
x

12/4
x
12/12
x
11/27
x
x

170

8.9

10/1

11/27

10/9

10/16

10/23

10/30

11/6

11/13

11/20

11/27

180

11.0

10/1

11/27

10/9
x

10/16
x

10/23
x

10/30
x

11/6
x

11/13
x

11/20
x

190

x

x

x

x

x

x

x

x

x

200

9.9

10/11

12/7

10/19

10/26

11/2

11/9

11/16

210

9.6

10/10

12/5

10/17

10/24

10/31

11/7

220

11.8

10/8

12/4

10/16

10/23

10/30

230

9.8

10/8

12/4

10/16

10/23

240

8.4

11/7

1/9/2
0

11/15

250

10.3

11/25

260

9.0

11/14

1/15/
20
1/9

CODES:

IA1C

SD

ED

EA1C

WC

11/2
8.9
11/11
9.0
12/2
office
11/22
home
11/24
7.5
11/11
8.7
11/15
7.7
x

8

11/22
home
11/23
home
11/27
home
12/4
home
12/12
home
11/27
home
x

3

4

11/27
x

11/27
call
11/27
home

x

x

x

x

11/23

11/30

12/7

5

11/14

11/21

11/28

12/5

11/6

11/13

11/20

11/27

12/4

10/30

11/6

11/13

11/20

11/27

12/4

11/22

11/29

12/6

12/13

12/20

12/27

1/2/
20

11/27

12/4

12/11

12/18

12/24

11/21

11/28

12/5

12/12

12/19

1/2/2
0
12/26

1/8/2
0
1/2/
20

1/15/
20
1/9/
20

12/7
office
12/5
home
12/4
home
12/4
home
1/2/
20
office
1/15/2
0
1/9/
20

8
3
8
8
8
8
x

6
4
x
x
x
x

x

6
0
3
8

8
8
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X= DID NOT START OR FINISH THE PROGRAM
PC= PARTICIPANT CODE. DOB= DATE OF BIRTH.
IA1C= INITIAL HBA1C, INITIAL SELF-CARE INVENTORY-REVISED TOOL, PATIENT-DRIVEN BEHAVIOR GOAL
SETTING.
SD= START DATE. ED= END DATE.
WK1= WEEK 1 CHECK POINT COMPLETED.
WK2= WEEK 2 CHECK POINT COMPLETED.
WK3= WEEK 3 CHECK POINT COMPLETED.
WK4= WEEK 3 CHECK POINT COMPLETED.
WK5= WEEK 3 CHECK POINT COMPLETED.
WK6= WEEK 5 CHECK POINT COMPLETED.
WK7= WEEK 7 CHECK POINT COMPLETED.
EA1C= (WEEK 8 CHECK POINT COMPLETED) END OF PROGRAM, FINAL HBA1C, REPEAT SELF-CARE
INVENTORY-REVISED TOOL, PARTICIPANT SATISFACTION SURVEY.
WC= WEEKS COMPLETED: 1= 1 WEEK, 2= 2 WEEKS, 3 = 3 WEEKS, 4= 4 WEEKS, 5= 5 WEEKS, 6 = 6 WEEKS, 7= 7
WEEKS, 8= 8 WEEKS.
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Tracking Calendar
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Appendix G
Patient Satisfaction Survey
*PLACE 1 CHECK FOR EACH LINE*
Please rate your experience with the use of the diabetes-specific mobile phone application
MySugr®
STRONGLY
AGREE =5
I found the
application
easy to upload
on my phone.
I found the
application
easy to use.
I found the
application
made it easy
to upload my
results to my
provider.
I found
application
helped me to
track my blood
sugar results.
I found the
application
helped me to
track my
physical
activity.
I found the
application
helped me to
track my
medications.
OVERALL, I
found the
application
helped me to
manage my
diabetes.

AGREE
=4

UNDECIDED
=3

DISAGREE
=2

STRONGLY
DISAGREE=1
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Appendix H
Behavior Tracking form
Living Sweet: A Multi-Functional Mobile-Phone Application Strategy for Adults with Uncontrolled
Type 2 Diabetes Mellitus

CODE

WEEK #

INITIAL A1C
Glucose/Goal:

WEEK 1
WEEK 2
WEEK 3
WEEK 4
WEEK 5
WEEK 6
WEEK 7
WEEK 8

Activity/Goal:
Medication/Goal:
FINAL A1C

GLUCOSE
1=MET
2= NOT MET

PHYSICAL
ACTIVITY
1=MET
2=NOT MET

MEDICATION
ADHERENCE
1=MET
2 = NOT MET

GLUCOSE
1=MET
2= NOT MET

PHYSICAL
ACTIVITY
1=MET
2=NOT MET

MEDICATION
ADHERENCE
1=MET
2 = NOT MET

WEEKS:

CODE

WEEK #

INITIAL A1C
Glucose/Goal:

WEEK 1
WEEK 2
WEEK 3
WEEK 4
WEEK 5
WEEK 6
WEEK 7
WEEK 8

Activity/Goal:
Medication/Goal:
FINAL A1C
WEEKS:
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Provider Information Sheet

Living Sweet:
An Adult Type 2 DM
Management Program
PROVIDER INFORMATION:
PURPOSE: This is an evidence driven project aimed at
reducing glycated hemoglobin, while fostering self-care
perception and self-care behaviors such as medication
adherence, blood glucose monitoring, and physical activity
engagement through the use of a diabetes-specific mobile
smart phone application.
INCLUSION CRITERIA: Participants must be 18 years or
older, have type II diabetes, have the most recent HbA1C of
greater than 8.0, and have access to a mobile smart phone.
Pregnant women are not able to be in this program.
GENERAL INFORMATION FOR PARTICIPANTS:
PROGRAM OVERVIEW:
• Free diabetes-specific mobile application to be down
loaded to the participant’s mobile smart phone.
(Android and iPhone compatible)
•

In person, hands-on and written instructions will be
provided by the project leader or designee. Access to
the project leader will be available 7 days a week for
trouble shooting and questions.

•

Patient-centered, individualized reminders and goals
will be set for each participant at the initial meeting and
can be adjusted throughout the pilot program to meet
individual needs of each participant.

•

Each participant will be encouraged to use the
application for a minimum of 8 weeks, and upload and
send results to the project leader or designee. After 8
weeks an HbA1C will be recorded. They may choose to
stop the program at any time for any reason.

PRODUCT:
• A diabetes-specific mobile application: Mysugr® will be
used for this pilot program to encourage selfmanagement behaviors that ultimately lead to improved
HbA1C results.
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EMR Referral Page
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Appendix K
Participant Privacy Log
Living Sweet: A Multi-Functional Mobile-Phone Application Strategy for Adults with Uncontrolled
Type 2 Diabetes Mellitus

NAME

CODE
001
002
003
004
005
006
007
008
009
110
120
130
140
150
160
170
180
190
200
210
220
230
240
250
260

DATE OF BIRTH

PHONE NUMBER

